0001144204-19-026186.txt : 20190515 0001144204-19-026186.hdr.sgml : 20190515 20190515062443 ACCESSION NUMBER: 0001144204-19-026186 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 48 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190515 DATE AS OF CHANGE: 20190515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Graf Industrial Corp. CENTRAL INDEX KEY: 0001745317 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38703 FILM NUMBER: 19824962 BUSINESS ADDRESS: STREET 1: 118 VINTAGE PARK BLVD STREET 2: SUITE W-222 CITY: HOUSTON STATE: TX ZIP: 77070 BUSINESS PHONE: 3107458669 MAIL ADDRESS: STREET 1: 118 VINTAGE PARK BLVD STREET 2: SUITE W-222 CITY: HOUSTON STATE: TX ZIP: 77070 10-Q 1 tv520948_10q.htm FORM 10-Q

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2019

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                      to

 

GRAF INDUSTRIAL CORP.

(Exact name of registrant as specified in its charter)

 

Delaware   001-38703   83-1138508

(State or other jurisdiction of

incorporation or organization) 

 

(Commission

File Number) 

 

(I.R.S. Employer

Identification Number) 

 

118 Vintage Park Blvd., Suite W-222

Houston, Texas 

  77070
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (281) 515-3517

 

Not Applicable

(Former name or former address, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ¨    No  x

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨   Accelerated filer   ¨
Non-accelerated filer   x   Smaller reporting company   x
Emerging growth company   x        

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  x    No  ¨

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading symbol(s) Name of each exchange on which registered

Units, each consisting of one share of common stock and one redeemable warrant

GRAF.U

The New York Stock Exchange

Common stock, par value $0.0001 per share GRAF The New York Stock Exchange
Warrants, each warrant exercisable for one-half of one share of common stock, each at an exercise price of $11.50 per share GRAF WS The New York Stock Exchange

 

As of May 15, 2019, 30,470,640 shares of common stock, par value $0.0001 per share were issued and outstanding.

 

 

 

 

 

 

GRAF INDUSTRIAL CORP.

Form 10-Q

Table of Contents

 

      Page
PART I. FINANCIAL INFORMATION   3
       
Item 1. Financial Statements   3
       
  Condensed Balance Sheets as of March 31, 2019 (Unaudited) and December 31, 2018   3
       
  Unaudited Condensed Statement of Operations for the three months ended March 31, 2019   4
       
  Unaudited Condensed Statement of Changes in Stockholders’ Equity for the three months ended March 31, 2019   5
       
  Unaudited Condensed Statement of Cash Flows for the three months ended March 31, 2019   6
       
  Notes to Unaudited Condensed Financial Statements   7
       
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   18
       
Item 3. Quantitative and Qualitative Disclosures About Market Risk   23
       
Item 4. Controls and Procedures   23
     
PART II. OTHER INFORMATION   23
       
Item 1. Legal Proceedings   23
       
Item 1A. Risk Factors   23
       
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities   24
       
Item 3. Defaults Upon Senior Securities   24
       
Item 4. Mine Safety Disclosures   24
       
Item 5. Other Information   24
       
Item 6. Exhibits   24

 

 2 

 

 

PART I. FINANCIAL INFORMATION

 

Item 1.Financial Statements

 

GRAF INDUSTRIAL CORP.

CONDENSED BALANCE SHEETS

 

   March 31, 2019   December 31, 2018 
   (Unaudited)     
Assets:          
Current assets:          
Cash  $1,174,616   $1,440,897 
Prepaid expenses   129,752    101,363 
Total current assets   1,304,368    1,542,260 
Investments held in Trust Account   246,312,667    244,890,301 
Total Assets  $247,617,035   $246,432,561 
           
Liabilities and Stockholders' Equity:          
Current liabilities:          
Accounts payable  $134,309   $110,177 
Accrued expenses   10,000    100,000 
Franchise tax payable   50,000    103,013 
Income tax payable   507,027    214,655 
Warrant liability   17,937,987    15,136,749 
Total current liabilities   18,639,323    15,664,594 
           
Commitments and Contingencies          
Common stock, $0.0001 par value; 22,397,771 and 22,576,796 shares subject to possible redemption (at $10.00 per share) at March 31, 2019 and December 31, 2018, respectively   223,977,710    225,767,960 
           
Stockholders' Equity:          
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding   -    - 
Common stock, $0.0001 par value; 400,000,000 shares authorized; 8,072,869 and 7,893,844 shares issued and outstanding (excluding 22,397,771 and 22,576,796 shares subject to possible redemption) at March 31, 2019 and December 31, 2018, respectively   807    789 
Additional paid-in capital   2,698,080    923,412 
Retained earnings   2,301,115    4,075,806 
Total stockholders' equity   5,000,002    5,000,007 
Total Liabilities and Stockholders' Equity  $247,617,035   $246,432,561 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 3 

 

 

GRAF INDUSTRIAL CORP. 
UNAUDITED CONDENSED STATEMENT OF OPERATIONS

 

   For The Three Months Ended 
   March 31, 2019 
     
Operating expenses:     
General and administrative costs  $103,447 
Loss from operations   (103,447)
      
Other incomes:     
Investment income on Trust Account   1,422,366 
Change in fair value of warrant liability   (2,801,238)
Total other incomes   (1,378,872)
      
Income before income tax expense   (1,482,319)
Income tax expense   (292,372)
Net loss  $(1,774,691)
      
Weighted average shares outstanding of Public Shares   24,376,512 
Basic and diluted net income per share, Public Shares  $0.05 
Weighted average shares outstanding of Founder Shares   6,094,128 
Basic and diluted net loss per share, Founder Shares  $(0.48)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 4 

 

 

GRAF INDUSTRIAL CORP. 
UNAUDITED CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

 

   For the three months ended March 31, 2019 
               Retained Earnings   Total 
   Common Stock   Additional Paid-In   (Accumulated   Stockholders' 
   Shares   Amount   Capital   Deficit)   Equity 
Balance - December 31, 2018   7,893,844   $789   $923,412   $4,075,806   $5,000,007 
Additional offering costs   -    -    (15,564)   -    (15,564)
Shares subject to possible redemption   179,025    18    1,790,232    -    1,790,250 
Net loss   -    -    -    (1,774,691)   (1,774,691)
Balance - March 31, 2019 (unaudited)   8,072,869   $807   $2,698,080   $2,301,115   $5,000,002 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 5 

 

 

GRAF INDUSTRIAL CORP. 
UNAUDITED CONDENSED STATEMENT OF CASH FLOWS 

 

   For The Three Months Ended 
   March 31, 2019 
Cash Flows from Operating Activities:     
Net loss  $(1,774,691)
Adjustments to reconcile net income to net cash used in operating activities:     
Income earned on investment held in Trust Account   (1,422,366)
Change in fair value of warrant liability   2,801,238 
Changes in operating assets and liabilities:     
Prepaid expenses   (28,389)
Accounts payable   24,132 
Accrued expenses   (5,000)
Franchise tax payable   (53,013)
Income tax payable   292,372 
Net cash used in operating activities   (165,717)
      
Cash Flows from Financing Activities:     
Payment of offering costs   (100,564)
Net cash provided by financing activities   (100,564)
      
Net change in cash   (266,281)
      
Cash - beginning of the period   1,440,897 
Cash - end of the period  $1,174,616 
      
Supplemental disclosure of noncash activities:     
 Change in value of common stock subject to possible redemption  $(1,790,250)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

 6 

 

 

GRAF INDUSTRIAL CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Note 1 — Description of Organization and Business Operations

 

Graf Industrial Corp. (the “Company”) is a blank check company incorporated in Delaware on June 26, 2018. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

 

The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

 

As of March 31, 2019, the Company had not commenced any operations. All activity up to March 31, 2019 relates to the Company’s formation and preparation for the initial public offering (“Initial Public Offering”), and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.

 

The registration statement for the Company’s Initial Public Offering was declared effective on October 15, 2018. On October 18, 2018, the Company consummated the Initial Public Offering of 22,500,000 units (the “Units” and, with respect to the shares of common stock included in the Units offered, the “Public Shares”), generating gross proceeds of $225 million, and incurred underwriting commissions of $4.5 million. On October 25, 2018, the Company consummated the closing of the sale of 1,876,512 additional Units upon receiving notice of the underwriters’ election to partially exercise their overallotment option (the “Over-allotment”), generating additional gross proceeds of approximately $18.8 million, and incurred additional underwriting commissions of $375,302 (Note 3).

 

Simultaneously with the closing of the Initial Public Offering and the Over-allotment, the Company consummated the private placement (“Private Placement”) of 14,150,605 warrants (the “Private Placement Warrants”) at a price of $0.50 per Private Placement Warrant, with the Sponsor, generating gross proceeds of approximately $7.08 million (Note 4).

 

Upon the closing of the Initial Public Offering, the Over-allotment and the Private Placement, approximately $243.8 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A. maintained by Continental Stock Transfer & Trust Company, acting as trustee (“Trust Account”). The proceeds held in the Trust Account was invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination, (ii) the redemption of any Public Shares properly submitted in connection with a stockholder vote to amend the Company’s Second Amended and Restated Certificate of Incorporation (the “Second Amended and Restated Certificate of Incorporation”) to modify the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 18 months from the closing of its Initial Public Offering or to provide for redemption in connection with a Business Combination and (iii) the redemption of the Company’s Public Shares if the Company is unable to complete a Business Combination within 18 months from the closing of its Initial Public Offering, subject to applicable law.

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, the Over-allotment and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. New York Stock Exchange (“NYSE”) rules require that the initial Business Combination must occur with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions). The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.

 

 7 

 

 

GRAF INDUSTRIAL CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption were recorded at a redemption value and classified as temporary equity in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to the Second Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Company’s Sponsor, officers and directors have agreed to vote their Founder Shares (as defined below in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction.

 

The Sponsor and the Company’s officers and directors have agreed (a) to waive their redemption rights with respect to their Founder Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Second Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination or to provide for redemption in connection with a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

 

If the Company is unable to complete a Business Combination within 18 months from the closing of the Initial Public Offering (by April 18, 2020) (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

 

 8 

 

 

GRAF INDUSTRIAL CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

The Sponsor and the Company’s officers and directors have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the officers, directors, the Sponsor or any of its members or their affiliates acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. Pursuant to the terms of the business combination marketing agreement (see Note 6), no fee will be payable if the Company does not complete a Business Combination. In the event that the Company does not complete a Business Combination and subsequently liquidates, the amount of such fee will be included with the funds held in the trust account that will be available to fund the redemption of Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

 

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to indemnify the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of  (i) $10.00 per Public Share or (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

Going Concern

 

As of March 31, 2019, the Company had approximately $1.2 million outside of the Trust Account, approximately $2.6 million of investment income available in the Trust Account to pay for franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), and a working capital surplus of approximately $603,000.

 

Through March 31, 2019, the Company’s liquidity needs have been satisfied through receipt of a $25,000 capital contribution from the Sponsor in exchange for the issuance of the Founder Shares (Note 5) to the Sponsor, $130,100 in loans and advances from the Sponsor and officer, and the net proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the loans and the advances to the Sponsor and officer in full on October 18, 2018.

 

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide Working Capital Loans (as defined in Note 5) to the Company. As of March 31, 2019, there were no Working Capital Loans.

 

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after April 18, 2020.

 

 9 

 

 

GRAF INDUSTRIAL CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Note 2 — Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2019 are not necessarily indicative of the results that may be expected through December 31, 2019.

 

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company's Annual Report on Form 10-K filed by the Company with the SEC on April 1, 2019.

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and the reported amounts of expenses during the period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Offering Costs

 

Offering costs consist of legal and accounting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs were charged to stockholders’ equity upon the completion of the Initial Public Offering in October 2018.

 

 10 

 

 

GRAF INDUSTRIAL CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Common Stock Subject to Possible Redemption

 

As discussed in Note 1, all of the 24,376,512 Public Shares may be redeemed under certain circumstances. In accordance with FASB ASC 480, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of FASB ASC 480. Although the Company did not specify a maximum redemption threshold, the Second Amended and Restated Certificate of Incorporation provides that in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets (stockholders’ equity) to be less than $5,000,001.

 

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the security at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock shall be affected by charges against additional paid-in capital. Accordingly, at March 31, 2019 and December 31, 2018, 22,397,771 and 22,576,796 Public Shares were classified outside of permanent equity, respectively.

 

Net Income Per Common Share

 

Net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the periods. The Company had not considered the effect of the warrants sold in the Initial Public Offering (including the consummation of the Over-allotment) and Private Placement to purchase an aggregate of 19,263,559 shares of the Company’s common stock in the calculation of diluted income per share, because their inclusion would be anti-dilutive under the treasury stock method.

 

The Company’s statement of operations includes a presentation of income per share for common stock subject to redemption in a manner similar to the two-class method of income per share. Net income per share, basic and diluted for Public Share is calculated by dividing the interest income earned on the Trust Account of approximately $1.4 million, net of applicable taxes and funds available to be withdrawn from the Trust Account, resulting in a total of approximately $1.2 million, by the weighted average number of Public Shares outstanding for the period. Net income per share, basic and diluted for Founder Shares (as defined in Note 5) is calculated by dividing the net income, less income attributable to Public Shares, by the weighted average number of Founder Shares outstanding for the period.

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of March 31, 2019 and December 31, 2018, the Company has a deferred tax asset of approximately $70,000 and $38,000, respectively, which has a full valuation allowance recorded against it.

 

The Company’s currently taxable income primarily consists of interest income on the Trust Account. The Company’s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three months ended March 31, 2019, the Company recorded income tax expense of approximately $292,000, primarily related to interest income earned on the Trust Account. The Company’s effective tax rate for the three months ended March 31, 2019 was approximately 20.9% which differs from the expected income tax rate due to the start-up costs (discussed above) which are not currently deductible.

 

FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2019 and December 31, 2018. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

 

 11 

 

 

GRAF INDUSTRIAL CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At March 31, 2019 and December 31, 2018, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

 

Fair Value Measurements

 

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

 

·Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
·Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
·Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

 

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

 

Warrant Liability

 

The Company accounts for certain common stock warrants outstanding as a liability at fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until the earlier of the consummation of the Business Combination or 15 months from the closing of the Initial Public Offering, and any change in fair value is recognized in the Company’s statements of operations. The fair value of the warrant liability is estimated using a binomial Monte-Carlo options pricing model, at each measurement date.

 

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

 

Note 3 — Initial Public Offering

 

The Company sold an aggregate of 24,376,512 Units, including 1,876,512 Units upon the underwriters’ election to partially exercise their overallotment option, at a price of $10.00 per Unit in the Initial Public Offering. Each Unit consists of one share of common stock and one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one-half of one share of common stock at a price of  $11.50 per whole share, provided that if the Company has not consummated a Business Combination within 15 months from the closing of the Initial Public Offering, each Public Warrant will entitle the holder thereof to purchase three-quarters of one share of common stock at a price of  $11.50 per whole share, subject to adjustment in either case (see Note 7). The Private Placement Warrants and the Public Warrants were classified as a liability at issuance due to this potential adjustment to the settlement amount.

 

 12 

 

 

GRAF INDUSTRIAL CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Note 4 — Private Placement

 

Concurrently with the closing of the Initial Public Offering and the Over-allotment, the Sponsor purchased an aggregate of 14,150,605 Private Placement Warrants at a price of  $0.50 per Private Placement Warrant, for an aggregate purchase price of approximately $7.08 million. Each Private Placement Warrant has the same terms as the Public Warrants. A portion of the net proceeds from the sale of the Private Placement Warrants were added to the proceeds from the Initial Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants and all underlying securities will expire worthless. The Sponsor has agreed not to transfer, assign or sell any of the Private Placement Warrants until the date that is 30 days after the completion of a Business Combination.

 

Note 5 — Related Party Transactions

 

Founder Shares

 

On June 26, 2018, the Sponsor purchased 8,625,000 shares (the “Founder Shares”) of the Company’s common stock for an aggregate price of $25,000. On September 13, 2018, the Sponsor returned to the Company, at no cost, 2,156,250 shares of common stock, which the Company cancelled, resulting in the Sponsor holding 6,468,750 Founder Shares. On October 9, 2018, the Sponsor transferred 25,000 Founder Shares at the same per-share price paid by the Sponsor to each of Keith Abell and Sabrina McKee, two of the Company’s directors (then director-nominees), resulting in the Sponsor holding 6,418,750 Founder Shares.

 

The Founder Shares included an aggregate of up to 843,750 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On October 25, 2018, the underwriters partially exercised their over-allotment option; thus, an aggregate of 374,622 Founder Shares was forfeited.

 

The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.

 

Related Party Loans

 

During the period from June 26, 2018 (inception) through December 31, 2018, the Sponsor had loaned the Company an aggregate of  $130,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Promissory Note”) and James A. Graf had advanced the Company $100 in connection with the initial establishment of a bank account. The Promissory Note and the advance from James A. Graf were non-interest bearing. The Company repaid the Promissory Note and the advances to James A. Graf on October 18, 2018.

 

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into additional warrants at a price of  $0.50 (or $0.75 if the Company has not consummated a Business Combination within 15 months from the closing of the Initial Public Offering) per warrant. As of March 31, 2019, there were no Working Capital Loans.

 

 13 

 

 

GRAF INDUSTRIAL CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Administrative Support Agreement

 

The Company agreed commencing on the effective date of the Initial Public Offering through the earlier of the Company’s consummation of a Business Combination and its liquidation, to reimburse an affiliate of its Sponsor up to $5,000 per month for office space, utilities and secretarial and administrative support on an at-cost basis to the extent such office space, utilities and support is not contracted with the Company directly.

 

The Company recorded and paid approximately $2,600 in expenses in connection with such agreement on the accompanying Statement of Operations for the three months ended March 31, 2019.

 

Note 6 — Commitments and Contingencies

 

Registration Rights

 

The holders of the Founder Shares, Private Placement Warrants (and any shares of common stock issuable upon the exercise of the Private Placement Warrants), and securities that may be issued upon conversion of Working Capital Loans will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of Initial Public Offering, requiring the Company to register such securities for resale. The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The Company granted the underwriters a 45-day option from the date of the prospectus relating to the Initial Public Offering to purchase up to 3,375,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters partially exercised this option on October 25, 2018 to purchase 1,876,512 additional Units.

 

The underwriters were entitled to a cash underwriting discount of $0.20 per Unit, or approximately $4.88 million in the aggregate, which was paid upon the closing of the Initial Public Offering.

 

Business Combination Marketing Agreement

 

The Company has engaged EarlyBirdCapital and Oppenheimer & Co. Inc. as advisors in connection with the Business Combination. The Company will pay EarlyBirdCapital and Oppenheimer & Co. Inc. for such services upon the consummation of the Business Combination (i) a cash fee in an amount equal to 3.5% of the gross proceeds of the Initial Public Offering (exclusive of any applicable finders’ fees which might become payable) an amount equal to up to 40% of which may, in the Company’s discretion, be allocated by the Company to other FINRA members, plus (ii) 150,000 shares of common stock to be issued to EarlyBirdCapital and/or its designees. EarlyBirdCapital and/or its designees will be entitled to registration rights requiring the Company to register such shares for resale. The Company has agreed to use its best efforts to effect such registration in connection with the consummation of the Business Combination or, if not then reasonably practicable, to use the Company’s best efforts to file a registration statement covering such shares within 15 days of the closing of the Business Combination. Pursuant to the terms of the business combination marketing agreement, no fee will be due if the Company does not complete a Business Combination. As of March 31, 2019, none of the above services have been substantially performed and accordingly no amounts have been recorded in the accompanying unaudited condensed financial statements.

 

 14 

 

 

GRAF INDUSTRIAL CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Note 7 — Warrant Liability

 

The Company has outstanding warrants to purchase an aggregate of 19,263,559 shares of the Company’s common stock issued in connection with the Initial Public Offering and the Private Placement (including warrants issued in connection with the consummation of the Over-allotment).

 

The Public Warrants may only be exercised for a whole number of shares. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of common stock issuable upon exercise of the Public Warrants. The Company will use its best efforts to cause the same to become effective and to maintain a current prospectus relating to those shares of common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective by the 60thbusiness day after the closing of a Business Combination, warrantholders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

 

Once the warrants become exercisable, the Company may redeem the Public Warrants:

 

·in whole and not in part;
·at a price of $0.01 per warrant;
·upon not less than 30 days’ prior written notice of redemption; and
·if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrantholders.

 

If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants.

 

The Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Initial Public Offering, except that the Private Placement Warrants and the common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. The Private Placement Warrants will be redeemable by the Company on the same basis as the Public Warrants.

 

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

 

 15 

 

 

GRAF INDUSTRIAL CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

The Company utilizes a binomial Monte-Carlo options pricing model to value the warrants at each reporting period, with changes in fair value recognized in the Statement of Operations. As such, the Company recorded $18,584,922 of warrant liabilities upon issuance as of October 18, 2018. For the three months ended March 31, 2019, the Company recorded a change in the fair value of the warrant liabilities in the amount of approximately $2.8 million on the statement of operations, resulting in warrant liabilities of $17,937,987 as of March 31, 2019 on the balance sheet.

 

The change in fair value of the warrant liabilities is summarized as follows:

 

Warrant liabilities at December 31, 2018 ​  $15,136,749 
Change in fair value of warrant liabilities   2,801,238 
Warrant liabilities at March 31, 2019  $17,937,987 

 

The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.

 

There were no transfers between Levels 1, 2 or 3 during the three months ended March 31, 2019.

 

The following table provides quantitative information regarding Level 3 fair value measurements as of March 31, 2019 and December 31, 2018:

 

   March 31,
2019
   December 31, 
2018
 
Exercise price  $11.50   $11.50 
Share price  $9.84   $9.60 
Volatility   65.0%   60%
Probability of completing a Business Combination   87.8%   86%
Expected life of the options to convert   5.72    5.97 
Risk-free rate   2.26%   2.55%
Dividend yield   0.0%   0.0%
Discount for lack of marketability (1)   15.0%   15.0%

 

(1)The discount for lack of marketability relates only to the Private Placement Warrants.

 

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2019 and December 31, 2018, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

Description  Level   March 31,
2019
 
Liabilities:          
Warrant liabilities   3   $17,937,987 
           

 

Description  Level   December 31, 
2018
 
Liabilities:          
Warrant liabilities   3   $15,136,749 

 

 16 

 

GRAF INDUSTRIAL CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

 

Note 8 — Fair Value Measurements

 

The following table presents information about the Company’s assets that are measured on a recurring basis as of March 31, 2019 and December 31, 2018 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.

 

March 31, 2019

 

Description  Quoted Prices in Active 
Markets (Level 1)
  

Significant Other
Observable Inputs
(Level 2)

   Significant Other 
Unobservable Inputs
(Level 3)
 
Investments held in Trust Account  $246,312,667         

 

December 31, 2018

Description  Quoted Prices in Active 
Markets (Level 1)
  

Significant Other

Observable Inputs
(Level 2)

   Significant Other 
Unobservable Inputs
(Level 3)
 
Investments held in Trust Account  $244,890,301         

 

At March 31, 2019 and December 31, 2018, approximately $2,400 and $500 of the balance in the Trust Account was held in cash, respectively.

 

Note 9 — Stockholders’ Equity

 

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At March 31, 2019 and December 31, 2018, there were no shares of preferred stock issued or outstanding.

 

Common Stock — The Company is authorized to issue 400,000,000 shares of common stock with a par value of $0.0001 per share. Holders of shares of common stock are entitled to one vote for each share. At March 31, 2019 and December 31, 2018, there were 30,470,640 shares of common stock issued or outstanding, including an aggregate of 22,397,771 and 22,576,796 shares of common stock classified outside of subject to possible redemption, respectively.

 

Note 10 — Subsequent Events

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were available to be issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

 

 17 

 

 

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

References to the “Company,” “our,” “us” or “we” refer to Graf Industrial Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q includes, and oral statements made from time to time by representatives of the Company may include, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this Form 10-Q. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings.

 

Overview

 

We are a blank check company incorporated in Delaware on June 26, 2018 and formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified (“business combination”). We are not limited to a particular industry or sector for purposes of consummating a business combination. Our sponsor is Graf Acquisition LLC, a Delaware limited liability company (the “sponsor”).

 

Our registration statement for the initial public offering (the “initial public offering”) was declared effective on October 15, 2018. On October 18, 2018, we consummated the initial public offering of 22,500,000 units (the “units” and, with respect to the shares of common stock included in the units offered, the “public shares”), generating gross proceeds of $225 million and incurred underwriting commissions of $4.5 million. On October 25, 2018, we consummated the closing of the sale of 1,876,512 additional units upon receiving notice of the underwriters’ election to partially exercise their overallotment option (the “over-allotment”), generating additional gross proceeds of approximately $18.8 million, and incurring $375,302 in underwriting commissions.

 

Simultaneously with the closing of the initial public offering and the over-allotment, we consummated the private placement (“private placement”) of 14,150,605 warrants (the “private placement warrants”) at a price of  $0.50 per private placement warrant, with our sponsor, Graf Acquisition LLC, a Delaware limited liability company (the “sponsor”), generating gross proceeds of approximately $7.08 million.

 

Upon the closing of the initial public offering, the over-allotment and the private placement, approximately $243.8 million ($10.00 per Unit) of the net proceeds of the sale of the units in the initial public offering and the private placement was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A. maintained by Continental Stock Transfer & Trust Company, acting as trustee (“trust account”). The proceeds held in the trust account were invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open ended investment company that holds itself out as a money market fund selected by us meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by us, until the earlier of: (i) the completion of a business combination, (ii) the redemption of any public shares properly submitted in connection with a stockholder vote to amend our second amended and restated certificate of incorporation (the “second amended and restated certificate of incorporation”) to modify the substance or timing of our obligation to redeem 100% of its public shares if we do not complete a business combination within 18 months from the closing of its initial public offering or to provide for redemption in connection with a business combination and (iii) the redemption of our public shares if the Company is unable to complete a business combination within 18 months from the closing of its initial public offering, subject to applicable law.

 

 18 

 

 

In order to protect the amounts held in the trust account, our sponsor has agreed to be liable to us if and to the extent any claims by a third party for services rendered or products sold to us, or a prospective target business with which we have entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of  (i) $10.00 per public share or (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the initial public offering against certain including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, we have not asked the sponsor to reserve for such indemnification obligations, nor have we independently verified whether the sponsor has sufficient funds to satisfy its indemnity obligations and believe that the sponsor’s only assets are securities of ours. Therefore, we cannot assure that the sponsor would be able to satisfy those obligations. None of our officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the sponsor will not be responsible to the extent of any liability for such third party claims. We will seek to reduce the possibility that the sponsor will have to indemnify the trust account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which we do business, execute agreements with us waiving any right, title, interest or claim of any kind in or to monies held in the trust account.

 

Our management has broad discretion with respect to the specific application of the net proceeds of the initial public offering, the Over-Allotment, and the private placement, although substantially all of the net proceeds are intended to be applied toward consummating a business combination.

 

Liquidity and Capital Resources

 

As of March 31, 2019, we had approximately $1.2 million outside of the trust account, approximately $2.6 million of investment income available in the trust account to pay for franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), and a working capital surplus of approximately $603,000.

 

Through March 31, 2019, our liquidity needs have been satisfied through receipt of a $25,000 capital contribution from our sponsor in exchange for the issuance of the founder shares to our sponsor, $130,100 in loans and advances from our sponsor and officer, and the net proceeds from the consummation of the private placement not held in Trust. We repaid the loans and advances to our sponsor and officer on October 18, 2018.

 

In addition, in order to finance transaction costs in connection with a business combination, our sponsor or an affiliate of our sponsor, or certain of our officers and directors may, but are not obligated to, loan us funds as may be required (“working capital loans”). As of March 31, 2019, there were no working capital loans.

 

Results of Operations

 

Our entire activity since inception up to March 31, 2019 related to our formation, commencement of the initial public offering, and since the closing of the initial public offering, the search for a prospective initial business combination. We will not be generating any operating revenues until the closing and completion of our initial business combination. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

 

For the three months ended March 31, 2019, we had net loss of approximately $1.8 million, which consisted of approximately $1.4 million in investment income, approximately $2.8 million in change in fair value of warrant liabilities, offset by approximately $103,000 in general and administrative costs, and approximately $292,000 in income tax expense.

 

 19 

 

 

Related Party Transactions

 

Founder Shares

 

On June 26, 2018, the sponsor purchased 8,625,000 shares (the “founder shares”) of our common stock for an aggregate price of $25,000. On September 13, 2018, the sponsor returned to us, at no cost, 2,156,250 shares of common stock, which we cancelled, resulting in the sponsor holding 6,468,750 founder shares. On October 9, 2018, the sponsor transferred 25,000 founder shares at the same per-share price paid by the sponsor to each of Keith Abell and Sabrina McKee, two of our directors (then director-nominees), resulting in the sponsor holding 6,418,750 founder shares.

 

The founder shares initially included an aggregate of up to 843,750 shares subject to forfeiture by the sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that out sponsor would own, on an as-converted basis, 20% of our issued and outstanding shares after the initial public offering. On October 25, 2018, the underwriters partially exercised their over-allotment option; thus, an aggregate of 374,622 founder shares was forfeited.

 

Our sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of its founder shares until the earlier to occur of: (A) one year after the completion of a business combination or (B) subsequent to a business combination, (x) if the last sale price of the common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a business combination, or (y) the date on which we complete a liquidation, merger, capital stock exchange or other similar transaction that results in all of our stockholders having the right to exchange their shares of common stock for cash, securities or other property.

 

Private Placement

 

Simultaneously with the closing of the initial public offering and the over-allotment, we consummated the private placement of 14,150,605 private placement warrants at a price of  $0.50 per private placement warrant, with the sponsor generating gross proceeds of approximately $7.08 million. The private placement warrants have the same terms as the warrants sold as components of the units in the initial public offering. Each private placement warrant is exercisable for one-half of one share of common stock at a price of $11.50 per whole share, provided that if we have not consummated a business combination within 15 months from the closing of the initial public offering, each private placement warrant will entitle the holder thereof to purchase three-quarters of one share of common stock at a price of  $11.50 per whole share, subject to adjustment in either case. A portion of the proceeds from the sale of the private placement warrants was added to the proceeds from the initial public offering to be held in the trust account. If we do not complete a business combination within the combination period, the private placement warrants will expire worthless.

 

Related Party Loans

 

During the period from June 26, 2018 (inception) through December 31, 2018, the sponsor had loaned us an aggregate of $130,000 to cover expenses related to the initial public offering pursuant to a promissory note (the “promissory note”) and James A. Graf had advanced us $100 in connection with the initial establishment of a bank account. The promissory note and the advance from James A. Graf were non-interest bearing. We repaid the promissory note and the advances to James A. Graf on October 18, 2018.

 

In addition, in order to finance transaction costs in connection with a business combination, the sponsor or an affiliate of the sponsor, or certain of our officers and directors may, but are not obligated to, loan us funds as may be required (“working capital loans”). If we complete a business combination, the Company would repay the working capital loans out of the proceeds of the trust account released to us. Otherwise, the working capital loans would be repaid only out of funds held outside the trust account. In the event that a business combination does not close, we may use a portion of proceeds held outside the trust account to repay the working capital loans but no proceeds held in the trust account would be used to repay the working capital loans. Except for the foregoing, the terms of such working capital loans, if any, have not been determined and no written agreements exist with respect to such loans. The working capital loans would either be repaid upon consummation of a business combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such working capital loans may be convertible into additional warrants at a price of $0.50 (or $0.75 if the Company has not consummated a business combination within 15 months from the closing of the initial public offering) per warrant. As of March 31, 2019, there were no working capital loans.

 

 20 

 

 

Administrative Support Agreement

 

We agreed commencing on the effective date of the initial public offering through the earlier of our consummation of a business combination and its liquidation, to reimburse an affiliate of its sponsor up to $5,000 per month for office space, utilities and secretarial and administrative support on an at-cost basis to the extent such office space, utilities and support is not contracted with us directly.

 

We recorded and paid approximately $2,600 in expenses in connection with such agreement on the accompanying Statement of Operations for the three months ended March 31, 2019.

 

Contractual Obligations

 

Registration Rights

 

The holders of the founder shares, private placement warrants (and any shares of common stock issuable upon the exercise of the private placement warrants), and securities that may be issued upon conversion of working capital loans will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of initial public offering, requiring us to register such securities for resale. The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a business combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that we will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. We will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

We granted the underwriters a 45-day option from the date of the prospectus relating to the initial public offering to purchase up to 3,375,000 additional units to cover over-allotments, if any, at the initial public offering price less the underwriting discounts and commissions. The underwriters partially exercised this option on October 25, 2018 to purchase 1,876,512 additional units.

 

The underwriters were entitled to a cash underwriting discount of $0.20 per Unit, or approximately $4.88 million in the aggregate, which was paid upon the closing of the initial public offering.

 

Business Combination Marketing Agreement

 

We have engaged EarlyBirdCapital and Oppenheimer & Co. Inc. as advisors in connection with the business combination. We will pay EarlyBirdCapital and Oppenheimer & Co. Inc. for such services upon the consummation of the business combination (i) a cash fee in an amount equal to 3.5% of the gross proceeds of the initial public offering (exclusive of any applicable finders’ fees which might become payable) an amount equal to up to 40% of which may, in our discretion, be allocated by us to other FINRA members, plus (ii) 150,000 shares of common stock to be issued to EarlyBirdCapital and/or its designees. EarlyBirdCapital and/or its designees will be entitled to registration rights requiring us to register such shares for resale. We have agreed to use its best efforts to effect such registration in connection with the consummation of the business combination or, if not then reasonably practicable, to use our best efforts to file a registration statement covering such shares within 15 days of the closing of the business combination. Pursuant to the terms of the business combination marketing agreement, no fee will be due if we do not complete a business combination.

 

 21 

 

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We had identified the following as its critical accounting policies:

 

Common Stock Subject to Possible Redemption

 

All of the 24,376,512 public shares may be redeemed under certain circumstances. In accordance with FASB ASC 480, redemption provisions not solely within our control require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of FASB ASC 480. Although we did not specify a maximum redemption threshold, the second amended and restated certificate of incorporation provides that in no event will we redeem our public shares in an amount that would cause our net tangible assets (stockholders’ equity) to be less than $5,000,001.

 

We recognize changes in redemption value immediately as they occur and adjusts the carrying value of the security at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock shall be affected by charges against additional paid-in capital. Accordingly, at March 31, 2019 and December 31, 2018, 22,397,771 and 22,576,796 public shares were classified outside of permanent equity, respectively.

 

Net Income Per Common Share

 

Net income per share is computed by dividing net income by the weighted-average number of common stock outstanding during the periods. We had not considered the effect of the warrants sold in the initial Public Offering (including warrants issued in connection with the consummation of the over-allotment) and private placement to purchase an aggregate of 19,263,559 shares of our common stock in the calculation of diluted income per share, since their inclusion would be anti-dilutive under the treasury stock method.

 

Our statement of operations includes a presentation of income per share for common stock subject to redemption in a manner similar to the two-class method of income per share. Net income per share, basic and diluted for public share is calculated by dividing the interest income earned on the trust account of approximately $1.4 million, net of applicable taxes and funds available to be withdrawn from Trust, resulting in a total of approximately $1.2 million, by the weighted average number of public shares outstanding for the period. Net income per share, basic and diluted for founder shares is calculated by dividing the net income, less income attributable to public shares, by the weighted average number of founder shares outstanding for the period.

 

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on our financial statements.

 

Off-Balance Sheet Arrangements

 

As of March 31, 2019, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual obligations.

 

 22 

 

 

JOBS Act

 

The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As such, our financial statements may not be comparable to companies that comply with public company effective dates.

 

Item 3.Quantitative and Qualitative Disclosures About Market Risk

 

As of March 31, 2019, we were not subject to any market or interest rate risk. Following the consummation of our Initial Public Offering, the net proceeds of our Initial Public Offering, including amounts in the Trust Account, were invested in U.S. government treasury bills, notes or bonds or in certain money market funds that invest solely in direct U.S. government treasury obligations. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.

 

We have not engaged in any hedging activities since our inception and we do not expect to engage in any hedging activities with respect to the market risk to which we are exposed.

 

Item 4.Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2018, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our chief executive officer and chief financial officer have concluded that during the period covered by this report, our disclosure controls and procedures were effective.

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control over Financial Reporting

 

There was no change in our internal control over financial reporting that occurred during the quarter ended March 31, 2019 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

PART II – OTHER INFORMATION

 

Item 1.Legal Proceedings

 

None.

 

Item 1A.Risk Factors.

 

As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our final prospectus filed with the SEC on October 16, 2018.

 

 23 

 

 

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities

 

On June 26, 2018, our Sponsor purchased an aggregate of 8,625,000 Founder Shares, for an aggregate offering price of $25,000 at an average purchase price of approximately $0.003 per share. On September 13, 2018, our Sponsor returned to us, at no cost, 2,156,250 shares of common stock, which we cancelled, resulting in our Sponsor holding 6,468,750 Founder Shares. On October 9, 2018, our Sponsor transferred 25,000 founder shares at the same per-share price paid by our Sponsor to each of Keith Abell and Sabrina McKee, two of our directors (then-director nominees), resulting in our Sponsor holding 6,418,750 Founder Shares. The number of Founder Shares issued was determined based on the expectation that the Founder Shares would represent 20% of the outstanding shares of common stock upon completion of the Initial Public Offering. Such securities were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. Each of our Sponsor and directors is an accredited investor for purposes of Rule 501 of Regulation D.

 

Simultaneously with the closing of the Initial Public Offering and the Over-allotment, we consummated the Private Placement of 14,150,605 Private Placement Warrants at a price of $0.50 per Private Placement Warrant, with the Sponsor generating gross proceeds of approximately $7.08 million. The Private Placement Warrants have the same terms as the warrants sold as components of the Units in the Initial Public Offering. Each Private Placement Warrant is exercisable for one-half of one share of common stock at a price of $11.50 per whole share, provided that if we have not consummated a Business Combination within 15 months from the closing of the Initial Public Offering, each Private Placement Warrant will entitle the holder thereof to purchase three-quarters of one share of common stock at a price of $11.50 per whole share, subject to adjustment in either case. A portion of the proceeds from the sale of the Private Placement Warrants was added to the proceeds from the Initial Public Offering to be held in the Trust Account. If we do not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless.

 

Use of Proceeds

 

On October 18, 2018, we consummated the Initial Public Offering of 22,500,000 Units, generating gross proceeds of $225 million. On October 25, 2018, we consummated the sale of 1,876,512 additional Units upon receiving notice of the underwriters’ election to partially exercise the Over-allotment, generating additional gross proceeds of approximately $18.8 million. Following the closing of the Initial Public Offering and the Private Placement, approximately $243.8 million was placed in the Trust Account.

 

There has been no material change in the planned use of proceeds from such use as described in the Company’s final prospectus (File No. 333-227396), dated October 15, 2018, which was declared effective by the SEC on October 15, 2018.

  

Item 3.Defaults Upon Senior Securities

 

None.

 

Item 4.Mine Safety Disclosures

 

None.

 

Item 5.Other Information

 

None.

 

Item 6.Exhibits.

 

Exhibit

Number

  Description
   
31.1   Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
31.2   Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
32.1   Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
32.2   Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
101.INS   XBRL Instance Document
   
101.SCH   XBRL Taxonomy Extension Schema Document
   
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
   
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document
   
101.LAB   XBRL Taxonomy Extension Label Linkbase Document
   
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document

 

 24 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on this 15th day of May, 2019.

 

  GRAF INDUSTRIAL CORP.
     
  By: /s/ James A. Graf
    Name: James A. Graf
    Title:  Chief Executive Officer

 

 25 

EX-31.1 2 tv520948_ex31-1.htm EXHIBIT 31.1

 

EXHIBIT 31.1

 

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, James A. Graf, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 of Graf Industrial Corp.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.[Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942];

 

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: May 15, 2019 By: /s/ James A. Graf
    James A. Graf
    Chief Executive Officer
(Principal Executive Officer)

 

 

EX-31.2 3 tv520948_ex31-2.htm EXHIBIT 31.2

 

EXHIBIT 31.2

 

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Michael Dee, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 of Graf Industrial Corp.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.[Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942];

 

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: May 15, 2019 By: /s/ Michael Dee
    Michael Dee
    President, Chief Financial Officer
(Principal Financial and Accounting Officer)

 

 

EX-32.1 4 tv520948_ex32-1.htm EXHIBIT 32.1

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Graf Industrial Corp. (the “Company”) on Form 10-Q for the quarter ended March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James A. Graf, Chief Executive Officer and Director of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 15, 2019

 

  /s/ James A. Graf
  Name: James A. Graf
  Title: Chief Executive Officer (Principal Executive Officer)

 

 

EX-32.2 5 tv520948_ex32-2.htm EXHIBIT 32.2

 

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Graf Industrial Corp. (the “Company”) on Form 10-Q for the quarter ended March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Dee, President, Chief Financial Officer and Director of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 15, 2019

 

  /s/ Michael Dee  
  Name: Michael Dee
  Title: President, Chief Financial Officer
(Principal Financial and Accounting Officer)

 

 

 

EX-101.INS 6 graf-20190331.xml XBRL INSTANCE DOCUMENT 0001745317 2019-01-01 2019-03-31 0001745317 2019-05-15 0001745317 2019-03-31 0001745317 2018-12-31 0001745317 2018-10-01 2018-10-25 0001745317 2018-09-13 0001745317 2018-10-01 2018-10-09 0001745317 2018-06-26 2018-12-31 0001745317 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001745317 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001745317 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001745317 us-gaap:PrivatePlacementMember 2019-01-01 2019-03-31 0001745317 us-gaap:IPOMember 2019-01-01 2019-03-31 0001745317 us-gaap:OverAllotmentOptionMember 2019-01-01 2019-03-31 0001745317 graf:SponsorMember 2019-01-01 2019-03-31 0001745317 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001745317 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2019-01-01 2019-03-31 0001745317 us-gaap:FairValueInputsLevel3Member 2019-01-01 2019-03-31 0001745317 srt:MaximumMember 2019-01-01 2019-03-31 0001745317 us-gaap:CommonStockMember 2019-03-31 0001745317 graf:SponsorMember 2019-03-31 0001745317 us-gaap:PrivatePlacementMember 2019-03-31 0001745317 us-gaap:IPOMember 2019-03-31 0001745317 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2019-03-31 0001745317 us-gaap:WarrantMember 2019-03-31 0001745317 us-gaap:FairValueInputsLevel1Member 2019-03-31 0001745317 us-gaap:FairValueInputsLevel2Member 2019-03-31 0001745317 us-gaap:FairValueInputsLevel3Member 2019-03-31 0001745317 us-gaap:CommonStockMember 2018-12-31 0001745317 graf:SponsorMember 2018-12-31 0001745317 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2018-12-31 0001745317 us-gaap:FairValueInputsLevel1Member 2018-12-31 0001745317 us-gaap:FairValueInputsLevel2Member 2018-12-31 0001745317 us-gaap:FairValueInputsLevel3Member 2018-12-31 0001745317 us-gaap:IPOMember 2018-10-01 2018-10-18 0001745317 us-gaap:WarrantMember 2018-10-01 2018-10-18 0001745317 us-gaap:OverAllotmentOptionMember 2018-10-01 2018-10-25 0001745317 us-gaap:PrivatePlacementMember 2018-10-01 2018-10-25 0001745317 us-gaap:FairValueInputsLevel3Member us-gaap:WarrantMember 2018-06-26 2018-12-31 0001745317 us-gaap:FairValueInputsLevel3Member 2018-06-26 2018-12-31 0001745317 graf:SponsorMember 2018-06-01 2018-06-27 0001745317 graf:SponsorMember 2018-09-01 2018-09-13 0001745317 us-gaap:DirectorMember 2018-10-01 2018-10-09 0001745317 us-gaap:IPOMember 2018-10-25 0001745317 us-gaap:CommonStockMember 2018-12-31 0001745317 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001745317 us-gaap:RetainedEarningsMember 2018-12-31 0001745317 us-gaap:CommonStockMember 2019-03-31 0001745317 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001745317 us-gaap:RetainedEarningsMember 2019-03-31 1174616 247617035 134309 10000 18639323 0 807 2698080 1440897 246432561 110177 100000 15664594 0 789 923412 2301115 5000002 247617035 4075806 5000007 246432561 -1774691 789 923412 4075806 5000007 7893844 0 0 -1774691 -1774691 8072869 807 2698080 2301115 5000002 -1774691 24132 -165717 100564 -100564 -266281 1440897 1174616 400000000 129752 1304368 246312667 50000 507027 17937987 223977710 101363 1542260 244890301 103013 214655 15136749 225767960 103447 -103447 1422366 2801238 22500000 225000000 4500000 1876512 18800000 375302 243800000 5000001 1.00 19263559 250000 24376512 1876512 10.00 11.50 14150605 0.50 7080000 8625000 25000 2156250 6468750 25000 6418750 843750 0.20 374622 12.00 130000 100 1500000 0.50 5000 3375000 1876512 0.20 4880000 0.035 0.40 150000 -1378872 -1482319 292372 24376512 0.05 6094128 -0.48 179025 18 1790232 0 1790250 0 15564 0 15564 1422366 28389 -5000 -53013 292372 -1790250 1200000 2600000 603000 25000 130100 24376512 22397771 22576796 1200000 1400000 2600 19263559 18584922 17937987 15136749 2400 500 246312667 0 0 244890301 0 0 22397771 22576796 0.0001 22397771 22576796 10.00 0.0001 10.00 0.0001 1000000 0.0001 1000000 0 0 0 0 0.0001 8072869 7893844 0.0001 400000000 8072869 7893844 <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 1&#8201;&#8212;&#8201;Description of Organization and Business Operations</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Graf Industrial Corp. (the &#8220;Company&#8221;) is a blank check company incorporated in Delaware on June&#160;26, 2018. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the &#8220;Business Combination&#8221;).</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of March 31, 2019, the Company had not commenced any operations. All activity up to March 31, 2019 relates to the Company&#8217;s formation and preparation for the initial public offering (&#8220;Initial Public Offering&#8221;), and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The&#160;Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The registration statement for the Company&#8217;s Initial Public Offering was declared effective on October&#160;15, 2018. On October 18, 2018, the Company consummated the Initial Public Offering of 22,500,000 units (the &#8220;Units&#8221; and, with respect to the shares of common stock included in the Units offered, the &#8220;Public Shares&#8221;), generating gross proceeds of&#8201;$225 million, and incurred underwriting commissions of $4.5 million. On October 25, 2018, the Company consummated the closing of the sale of 1,876,512 additional Units upon receiving notice of the underwriters&#8217; election to partially exercise their overallotment option (the &#8220;Over-allotment&#8221;), generating additional gross proceeds of approximately $18.8&#160;million, and incurred additional underwriting commissions of&#8201;$375,302 (Note 3).</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the Initial Public Offering and the Over-allotment, the Company consummated the private placement (&#8220;Private Placement&#8221;) of 14,150,605 warrants (the &#8220;Private Placement Warrants&#8221;) at a price of $0.50 per Private Placement Warrant, with the Sponsor, generating gross proceeds of approximately $7.08 million (Note 4).</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upon the closing of the Initial Public Offering, the Over-allotment and the Private Placement, approximately $243.8 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A. maintained by Continental Stock Transfer &amp; Trust Company, acting as trustee (&#8220;Trust Account&#8221;). <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The proceeds held in the Trust Account was invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act 1940, as amended (the &#8220;Investment Company Act&#8221;), with a maturity of 180 days or less or in any open ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination, (ii) the redemption of any Public Shares properly submitted in connection with a stockholder vote to amend the Company&#8217;s Second Amended and Restated Certificate of Incorporation (the &#8220;Second Amended and Restated Certificate of Incorporation&#8221;) to modify the substance or timing of the Company&#8217;s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 18 months from the closing of its Initial Public Offering or to provide for redemption in connection with a Business Combination and (iii) the redemption of the Company&#8217;s Public Shares if the Company is unable to complete a Business Combination within 18 months from the closing of its Initial Public Offering, subject to applicable law.</div></div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, the Over-allotment and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. New York Stock Exchange (&#8220;NYSE&#8221;) rules require that the initial Business Combination must occur with one or more operating businesses or assets with a <div style="letter-spacing: 0px; top: 0px;;display:inline;">fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions)</div>. The Company will only complete a Business Combination if the post-transaction company owns or <div style="letter-spacing: 0px; top: 0px;;display:inline;">acquires 50% or more of the outstanding voting securities of the target</div> or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will provide its holders of the outstanding Public Shares (the &#8220;public stockholders&#8221;) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account. There will be no redemption rights upon the completion of a Business Combination with respect to the Company&#8217;s warrants. The Public Shares subject to redemption were recorded at a redemption value and classified as temporary equity in accordance with the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to the Second Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Company&#8217;s Sponsor, officers and directors have agreed to vote their Founder Shares (as defined below in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor and the Company&#8217;s officers and directors have agreed (a) to waive their redemption rights with respect to their Founder Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Second Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company&#8217;s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination or to provide for redemption in connection with a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Company is unable to complete a Business Combination within 18 months from the closing of the Initial Public Offering (by April 18, 2020) (the &#8220;Combination Period&#8221;), the Company will <div style="letter-spacing: 0px; top: 0px;;display:inline;">(i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law,</div> and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#8217;s remaining stockholders and the Company&#8217;s board of directors, dissolve and liquidate, subject in each case to the Company&#8217;s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company&#8217;s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor and the Company&#8217;s officers and directors have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the officers, directors, the Sponsor or any of its members or their affiliates acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. Pursuant to the terms of the business combination marketing agreement (see Note 6), no fee will be payable if the Company does not complete a Business Combination. In the event that the Company does not complete a Business Combination and subsequently liquidates, the amount of such fee will be included with the funds held in the trust account that will be available to fund the redemption of Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit&#160;($10.00).</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In order to protect the amounts held in the Trust Account, the Sponsor has agreed to indemnify the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of&#160;&#160;(i) $10.00 per Public Share or (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the Initial Public Offering against certain including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor&#8217;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company&#8217;s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company&#8217;s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-weight:bold;display:inline;">Going Concern</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of March 31, 2019, the Company had approximately $1.2 million outside of the Trust Account, approximately $2.6 million of investment income available in the Trust Account to pay for franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), and a working capital surplus of approximately $603,000.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Through March 31, 2019, the Company&#8217;s liquidity needs have been satisfied through receipt of a $25,000 capital contribution from the Sponsor in exchange for the issuance of the Founder Shares (Note 5) to the Sponsor, $130,100 in loans and advances from the Sponsor and officer, and the net proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the loans and the advances to the Sponsor and officer in full on October 18, 2018.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, provide Working Capital Loans (as defined in Note 5) to the Company. As of March 31, 2019, there were no Working Capital Loans.</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;">&#160;</div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;">In connection with the Company&#8217;s assessment of going concern considerations in accordance with Financial Accounting Standard Board&#8217;s Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, &#8220;Disclosures of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern,&#8221; management has determined that the mandatory liquidation and subsequent dissolution raises substantial doubt about the Company&#8217;s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after April 18, 2020.</div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> The proceeds held in the Trust Account was invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act 1940, as amended (the &#8220;Investment Company Act&#8221;), with a maturity of 180 days or less or in any open ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination, (ii) the redemption of any Public Shares properly submitted in connection with a stockholder vote to amend the Company&#8217;s Second Amended and Restated Certificate of Incorporation (the &#8220;Second Amended and Restated Certificate of Incorporation&#8221;) to modify the substance or timing of the Company&#8217;s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 18 months from the closing of its Initial Public Offering or to provide for redemption in connection with a Business Combination and (iii) the redemption of the Company&#8217;s Public Shares if the Company is unable to complete a Business Combination within 18 months from the closing of its Initial Public Offering, subject to applicable law.&#8203;&#8203;&#8203;&#8203;&#8203;&#8203;&#8203; fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions) acquires 50% or more of the outstanding voting securities of the target (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders&#8217; rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, 10.00 <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 2&#8201;&#8212;&#8201;Summary of Significant Accounting Policies</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Basis of Presentation</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2019 are not necessarily indicative of the results that may be expected through December 31, 2019.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.31in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, serif; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company's Annual Report on Form 10-K filed by the Company with the SEC on April 1, 2019.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Emerging Growth Company</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Use of Estimates</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, serif; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; font-size: 10pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and the reported amounts of expenses during the period.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Offering Costs</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offering costs consist of legal and accounting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs were charged to stockholders&#8217; equity upon the completion of the Initial Public Offering in October 2018.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Common Stock Subject to Possible Redemption</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As discussed in Note 1, all of the 24,376,512 Public Shares may be redeemed under certain circumstances. In accordance with FASB ASC 480, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity&#8217;s equity instruments, are excluded from the provisions of FASB ASC 480. Although the Company did not specify a maximum redemption threshold, the Second Amended and Restated Certificate of Incorporation provides that in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets (stockholders&#8217; equity) to be less than $5,000,001.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the security at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock shall be affected by charges against additional paid-in capital. Accordingly, at March 31, 2019 and December 31, 2018, 22,397,771 and 22,576,796 Public Shares were classified outside of permanent equity, respectively.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Net Income Per Common Share</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the periods. The Company had not considered the effect of the warrants sold in the Initial Public Offering (including the consummation of the Over-allotment) and Private Placement to purchase an aggregate of 19,263,559 shares of the Company&#8217;s common stock in the calculation of diluted income per share, because their inclusion would be anti-dilutive under the treasury stock method.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s statement of operations includes a presentation of income per share for common stock subject to redemption in a manner similar to the two-class method of income per share. Net income per share, basic and diluted for Public Share is calculated by dividing the interest income earned on the Trust Account of approximately $1.4 million, net of applicable taxes and funds available to be withdrawn from the Trust Account, resulting in a total of approximately $1.2 million, by the weighted average number of Public Shares outstanding for the period. Net income per share, basic and diluted for Founder Shares (as defined in Note&#160;5) is calculated by dividing the net income, less income attributable to Public Shares, by the weighted average number of Founder Shares outstanding for the period.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Income Taxes</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, serif; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; font-size: 10pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company follows the asset and liability method of accounting for income taxes under FASB ASC&#160;740, &#8220;Income Taxes.&#8221; Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&#160;</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of March 31, 2019 and December 31, 2018, the Company has a deferred tax asset of approximately $70,000 and $38,000, respectively, which has a full valuation allowance recorded against it.</div></div><div style="margin: 0px 0in; text-align: justify; text-indent: 0.25in; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none;"><div style="font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="margin: 0in 0in 0.0001pt; text-align: justify; text-indent: 0.25in; font-family: &quot;times new roman&quot;, serif; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s currently taxable income primarily consists of interest income on the Trust Account. The Company&#8217;s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three months ended March 31, 2019, the Company recorded income tax expense of approximately $292,000, primarily related to interest income earned on the Trust Account. The Company&#8217;s effective tax rate for the three months ended March 31, 2019 was approximately 20.9% which differs from the expected income tax rate due to the start-up costs (discussed above) which are not currently deductible.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2019 and December 31, 2018. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Concentration of Credit Risk</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of&#8201;$250,000. At March 31, 2019 and December 31, 2018, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Fair Value of Financial Instruments</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under FASB ASC 820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Fair Value Measurements</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div><table style="border: none; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; table-layout: fixed;"><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: symbol; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#61623;</div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</div></div></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: symbol; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#61623;</div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</div></div></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: symbol; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#61623;</div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div><div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div></div><div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Warrant Liability</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for certain common stock warrants outstanding as a liability at fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until the earlier of the consummation of the Business Combination or 15 months from the closing of the Initial Public Offering, and any change in fair value is recognized in the Company&#8217;s statements of operations. The fair value of the warrant liability is estimated using a binomial Monte-Carlo options pricing model, at each measurement date.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Recent Accounting Pronouncements</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, serif; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#8217;s unaudited condensed financial statements.</div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Basis of Presentation</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2019 are not necessarily indicative of the results that may be expected through December 31, 2019.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.31in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, serif; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company's Annual Report on Form 10-K filed by the Company with the SEC on April 1, 2019.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Use of Estimates</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, serif; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; font-size: 10pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and the reported amounts of expenses during the period.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Offering Costs</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offering costs consist of legal and accounting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs were charged to stockholders&#8217; equity upon the completion of the Initial Public Offering in October 2018.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Common Stock Subject to Possible Redemption</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As discussed in Note 1, all of the 24,376,512 Public Shares may be redeemed under certain circumstances. In accordance with FASB ASC 480, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity&#8217;s equity instruments, are excluded from the provisions of FASB ASC 480. Although the Company did not specify a maximum redemption threshold, the Second Amended and Restated Certificate of Incorporation provides that in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets (stockholders&#8217; equity) to be less than $5,000,001.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the security at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock shall be affected by charges against additional paid-in capital. Accordingly, at March 31, 2019 and December 31, 2018, 22,397,771 and 22,576,796 Public Shares were classified outside of permanent equity, respectively.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Net Income Per Common Share</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the periods. The Company had not considered the effect of the warrants sold in the Initial Public Offering (including the consummation of the Over-allotment) and Private Placement to purchase an aggregate of 19,263,559 shares of the Company&#8217;s common stock in the calculation of diluted income per share, because their inclusion would be anti-dilutive under the treasury stock method.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s statement of operations includes a presentation of income per share for common stock subject to redemption in a manner similar to the two-class method of income per share. Net income per share, basic and diluted for Public Share is calculated by dividing the interest income earned on the Trust Account of approximately $1.4 million, net of applicable taxes and funds available to be withdrawn from the Trust Account, resulting in a total of approximately $1.2 million, by the weighted average number of Public Shares outstanding for the period. Net income per share, basic and diluted for Founder Shares (as defined in Note&#160;5) is calculated by dividing the net income, less income attributable to Public Shares, by the weighted average number of Founder Shares outstanding for the period.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Income Taxes</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, serif; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; font-size: 10pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company follows the asset and liability method of accounting for income taxes under FASB ASC&#160;740, &#8220;Income Taxes.&#8221; Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&#160;</div><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of March 31, 2019 and December 31, 2018, the Company has a deferred tax asset of approximately $70,000 and $38,000, respectively, which has a full valuation allowance recorded against it.</div></div><div style="margin: 0px 0in; text-align: justify; text-indent: 0.25in; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none;"><div style="font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="margin: 0in 0in 0.0001pt; text-align: justify; text-indent: 0.25in; font-family: &quot;times new roman&quot;, serif; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s currently taxable income primarily consists of interest income on the Trust Account. The Company&#8217;s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three months ended March 31, 2019, the Company recorded income tax expense of approximately $292,000, primarily related to interest income earned on the Trust Account. The Company&#8217;s effective tax rate for the three months ended March 31, 2019 was approximately 20.9% which differs from the expected income tax rate due to the start-up costs (discussed above) which are not currently deductible.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2019 and December 31, 2018. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Concentration of Credit Risk</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of&#8201;$250,000. At March 31, 2019 and December 31, 2018, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Fair Value of Financial Instruments</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under FASB ASC 820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Warrant Liability</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for certain common stock warrants outstanding as a liability at fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until the earlier of the consummation of the Business Combination or 15 months from the closing of the Initial Public Offering, and any change in fair value is recognized in the Company&#8217;s statements of operations. The fair value of the warrant liability is estimated using a binomial Monte-Carlo options pricing model, at each measurement date.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Recent Accounting Pronouncements</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, serif; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company&#8217;s unaudited condensed financial statements.</div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Emerging Growth Company</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an &#8220;emerging growth company,&#8221; as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Fair Value Measurements</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div><table style="border: none; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; table-layout: fixed;"><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: symbol; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#61623;</div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</div></div></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: symbol; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#61623;</div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</div></div></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: symbol; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#61623;</div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div><div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div></div><div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 70000 38000 0.209 0 0 <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 3&#8201;&#8212;&#8201;Initial Public Offering</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company sold an aggregate of 24,376,512 Units, including 1,876,512 Units upon the underwriters&#8217; election to partially exercise their overallotment option, at a price of&#8201;$10.00 per Unit in the Initial Public Offering. Each Unit consists of one share of common stock and one redeemable warrant (&#8220;Public Warrant&#8221;). Each Public Warrant entitles the holder to purchase one-half of one share of common stock at a price of&#8201;&#8201;$11.50 per whole share, provided that if the Company has not consummated a Business Combination within 15 months from the closing of the Initial Public Offering, each Public Warrant will entitle the holder thereof to purchase three-quarters of one share of common stock at a price of&#8201;&#8201;$11.50 per whole share, subject to adjustment in either case (see Note 7). The Private Placement Warrants and the Public Warrants were classified as a liability at issuance due to this potential adjustment to the settlement amount.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 4&#8201;&#8212;&#8201;Private Placement</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concurrently with the closing of the Initial Public Offering and the Over-allotment, the Sponsor purchased an aggregate of 14,150,605 Private Placement Warrants at a price of&#8201;&#8201;$0.50 per Private Placement Warrant, for an aggregate purchase price of&#8201;approximately $7.08 million. Each Private Placement Warrant has the same terms as the Public Warrants. A portion of the net proceeds from the sale of the Private Placement Warrants were added to the proceeds from the Initial Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants and all underlying securities will expire worthless. The Sponsor has agreed not to transfer, assign or sell any of the Private Placement Warrants until the date that is 30 days after the completion of a Business Combination.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 5&#8201;&#8212;&#8201;Related Party Transactions</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Founder Shares</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On June 26, 2018, the Sponsor purchased 8,625,000 shares (the &#8220;Founder Shares&#8221;) of the Company&#8217;s common stock for an aggregate price of&#8201;$25,000. On September 13, 2018, the Sponsor returned to the Company, at no cost, 2,156,250 shares of common stock, which the Company cancelled, resulting in the Sponsor holding 6,468,750 Founder Shares. On October 9, 2018, the Sponsor transferred 25,000 Founder Shares at the same per-share price paid by the Sponsor to each of Keith Abell and Sabrina McKee, two of the Company&#8217;s directors (then director-nominees), resulting in the Sponsor holding 6,418,750 Founder Shares.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Founder Shares included an aggregate of up to 843,750 shares subject to forfeiture by the Sponsor to the extent that the underwriters&#8217; over-allotment was not exercised in full or in part, so that the Sponsor would own, on an as-converted basis, 20% of the Company&#8217;s issued and outstanding shares after the Initial Public Offering. On October 25, 2018, the underwriters partially exercised their over-allotment option; thus, an aggregate of 374,622 Founder Shares was forfeited.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company&#8217;s stockholders having the right to exchange their shares of common stock for cash, securities or other property.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Related Party Loans</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the period from June 26, 2018 (inception) through December 31, 2018, the Sponsor had loaned the Company an aggregate of&#160;&#160;$130,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the &#8220;Promissory Note&#8221;) and James A. Graf had advanced the Company $100 in connection with the initial establishment of a bank account. The Promissory Note and the advance from James A. Graf were non-interest bearing. The Company repaid the Promissory Note and the advances to James A. Graf on October 18, 2018.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital Loans&#8221;). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender&#8217;s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into additional warrants at a price of&#8201;&#8201;$0.50 (or $0.75 if the Company has not consummated a Business Combination within 15 months from the closing of the Initial Public Offering) per warrant. As of March 31, 2019, there were no Working Capital Loans.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Administrative Support Agreement</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company agreed commencing on the effective date of the Initial Public Offering through the earlier of the Company&#8217;s consummation of a Business Combination and its liquidation, to reimburse an affiliate of its Sponsor up to $5,000 per month for office space, utilities and secretarial and administrative support on an at-cost basis to the extent such office space, utilities and support is not contracted with the Company directly.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company recorded and paid approximately $2,600 in expenses in connection with such agreement on the accompanying Statement of Operations for the three months ended March 31, 2019.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> $0.75 if the Company has not consummated a Business Combination within 15 months from the closing of the Initial Public Offering) per warrant. <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 6&#8201;&#8212;&#8201;Commitments and Contingencies</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Registration Rights</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The holders of the Founder Shares, Private Placement Warrants (and any shares of common stock issuable upon the exercise of the Private Placement Warrants), and securities that may be issued upon conversion of Working Capital Loans will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of Initial Public Offering, requiring the Company to register such securities for resale. The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Underwriting Agreement</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company granted the underwriters a 45-day option from the date of the prospectus relating to the Initial Public Offering to purchase up to 3,375,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters partially exercised this option on October 25, 2018 to purchase 1,876,512 additional Units.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The underwriters were entitled to a cash underwriting discount of&#8201;$0.20 per Unit, or approximately $4.88 million in the aggregate, which was paid upon the closing of the Initial Public Offering.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Business Combination Marketing Agreement</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="margin: 0in 0in 0.0001pt; text-align: justify; text-indent: 0.25in; font-family: &quot;times new roman&quot;, serif; font-size: 10pt;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has engaged EarlyBirdCapital and Oppenheimer &amp; Co. Inc. as advisors in connection with the Business Combination. The Company will pay EarlyBirdCapital and Oppenheimer &amp; Co. Inc. for such services upon the consummation of the Business Combination (i) a cash fee in an amount equal to 3.5% of the gross proceeds of the Initial Public Offering (exclusive of any applicable finders&#8217; fees which might become payable) an amount equal to up to 40% of which may, in the Company&#8217;s discretion, be allocated by the Company to other FINRA members, plus (ii) 150,000 shares of common stock to be issued to EarlyBirdCapital and/or its designees. EarlyBirdCapital and/or its designees will be entitled to registration rights requiring the Company to register such shares for resale. The Company has agreed to use its best efforts to effect such registration in connection with the consummation of the Business Combination or, if not then reasonably practicable, to use the Company&#8217;s best efforts to file a registration statement covering such shares within 15 days of the closing of the Business Combination. Pursuant to the terms of the business combination marketing agreement, no fee will be due if the Company does not complete a Business Combination. As of March 31, 2019, none of the above services have been substantially performed and accordingly no amounts have been recorded in the accompanying unaudited condensed financial statements.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The change in fair value of the warrant liabilities is summarized as follows:</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 60%;margin-left: auto;margin-right: auto;"><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 87.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liabilities at December 31, 2018 </div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">15,136,749</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of warrant liabilities</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2,801,238</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 2.5pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liabilities at March 31, 2019</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 2.5pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: double #000000 2.5pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #cceeff;border-bottom: double #000000 2.5pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">17,937,987</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-style: none; border-color: initial; padding: 0px 0px 1.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td></tr></table><div style="clear: both; max-height: 0px;"></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides quantitative information regarding Level 3 fair value measurements as of March 31, 2019 and December 31, 2018:</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 80%;margin-left: auto;margin-right: auto;"><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,&#160;</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 74.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercise price</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">11.50</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">11.50</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Share price</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">9.84</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">9.60</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">65.0</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">60</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Probability of completing a Business Combination</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">87.8</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">86</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected life of the options to convert</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">5.72</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">5.97</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2.26</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2.55</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">0.0</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">0.0</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discount for lack of marketability (1)</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">15.0</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">15.0</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div><table style="border: none; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; table-layout: fixed;"><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(1)</div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The discount for lack of marketability relates only to the Private Placement Warrants.</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 7&#8201;&#8212;&#8201;Warrant Liability</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has outstanding warrants to purchase an aggregate of 19,263,559 shares of the Company&#8217;s common stock issued in connection with the Initial Public Offering and the Private Placement (including warrants issued in connection with the consummation of the Over-allotment).</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Public Warrants may only be exercised for a whole number of shares. The Public Warrants will become exercisable on the later of&#8201;(a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of common stock issuable upon exercise of the Public Warrants. The Company will use its best efforts to cause the same to become effective and to maintain a current prospectus relating to those shares of common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective by the 60thbusiness day after the closing of a Business Combination, warrantholders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a &#8220;covered security&#8221; under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Once the warrants become exercisable, the Company may redeem the Public Warrants:</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="border: none;border-collapse: collapse;margin-bottom: 0.001pt;width: 100%;table-layout: fixed;margin-right: auto;"><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: symbol; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#61623;</div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part;</div></div></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: symbol; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#61623;</div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of&#8201;$<div style="letter-spacing: 0px; top: 0px;;display:inline;">0.01</div> per warrant;</div></div></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: symbol; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#61623;</div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">upon not less than 30 days&#8217; prior written notice of redemption; and</div></div></div></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: symbol; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#61623;</div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">if, and only if, the reported last sale price of the Company&#8217;s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrantholders.</div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div><div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div></div><div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div></div><div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Initial Public Offering, except that the Private Placement Warrants and the common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. The Private Placement Warrants will be redeemable by the Company on the same basis as the Public Warrants.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a &#8220;cashless basis,&#8221; as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company utilizes a binomial Monte-Carlo options pricing model to value the warrants at each reporting period, with changes in fair value recognized in the Statement of Operations. As such, the Company recorded $18,584,922 of warrant liabilities upon issuance as of October 18, 2018. For the three months ended March 31, 2019, the Company recorded a change in the fair value of the warrant liabilities in the amount of approximately $2.8 million on the statement of operations, resulting in warrant liabilities of $17,937,987 as of March 31, 2019 on the balance sheet.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The change in fair value of the warrant liabilities is summarized as follows:</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 60%;margin-left: auto;margin-right: auto;"><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 87.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liabilities at December 31, 2018 </div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">15,136,749</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in fair value of warrant liabilities</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2,801,238</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 2.5pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liabilities at March 31, 2019</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 2.5pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: double #000000 2.5pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #cceeff;border-bottom: double #000000 2.5pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">17,937,987</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-style: none; border-color: initial; padding: 0px 0px 1.5pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="font-size: 10pt; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="font-family: &quot;times new roman&quot;, serif; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; font-size: 10pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There were no transfers between Levels 1, 2 or 3 during the three months ended March 31, 2019.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides quantitative information regarding Level 3 fair value measurements as of March 31, 2019 and December 31, 2018:</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 80%;margin-left: auto;margin-right: auto;"><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,&#160;</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 74.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Exercise price</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">11.50</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">11.50</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Share price</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">9.84</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">9.60</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">65.0</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">60</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Probability of completing a Business Combination</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">87.8</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">86</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Expected life of the options to convert</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">5.72</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">5.97</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2.26</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2.55</div></div></td><td style="background: rgb(255, 255, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">0.0</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">0.0</div></div></td><td style="background: rgb(204, 238, 255); border-width: initial; border-style: none; border-color: initial; padding-bottom: initial; padding-left: 0px; padding-right: 0px; padding-top: 0pt; vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr><tr><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Discount for lack of marketability (1)</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">15.0</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">15.0</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">%</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div><table style="border: none; border-collapse: collapse; margin-bottom: 0.001pt; width: 100%; table-layout: fixed;"><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;">&#160;</div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;width: 18pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(1)</div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: top;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The discount for lack of marketability relates only to the Private Placement Warrants.</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis at March 31, 2019 and December 31, 2018, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 50%;margin-left: auto;margin-right: auto;"><tr><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 74.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liabilities</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">17,937,987</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 50%;margin-left: auto;margin-right: auto;"><tr><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; text-align: center;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,&#160;</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 74.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liabilities</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">15,136,749</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company&#8217;s assets that are measured at fair value on a recurring basis at March 31, 2019 and December 31, 2018, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 50%;margin-left: auto;margin-right: auto;"><tr><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31,</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2019</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 74.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liabilities</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">17,937,987</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 50%;margin-left: auto;margin-right: auto;"><tr><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; text-align: center;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31,&#160;</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2018</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr><tr><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 74.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liabilities</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">15,136,749</div></div></td><td style="background: #ffffff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none; margin-bottom: 0px; margin-top: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 15136749 2801238 17937987 <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 8&#8201;&#8212;&#8201;Fair Value Measurements</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company&#8217;s assets that are measured on a recurring basis as of March 31, 2019 and December 31, 2018 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2019</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 100%;"><tr><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted&#160;Prices&#160;in Active&#160;</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Markets (Level 1)</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant&#160;Other</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Observable&#160;Inputs</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 2)</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant&#160;Other&#160;</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable&#160;Inputs</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 3)</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 61.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments held in Trust Account</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">246,312,667</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2018</div></div></div><div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 100%;"><tr><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted&#160;Prices&#160;in Active&#160;</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Markets (Level 1)</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant&#160;Other</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Observable&#160;Inputs</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 2)</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant&#160;Other&#160;</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable&#160;Inputs</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 3)</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 61.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments held in Trust Account</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">244,890,301</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At March 31, 2019 and December 31, 2018, approximately $2,400 and $500 of the balance in the Trust Account was held in cash, respectively.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company&#8217;s assets that are measured on a recurring basis as of March 31, 2019 and December 31, 2018 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 31, 2019</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 100%;"><tr><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted&#160;Prices&#160;in Active&#160;</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Markets (Level 1)</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant&#160;Other</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Observable&#160;Inputs</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 2)</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant&#160;Other&#160;</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable&#160;Inputs</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 3)</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 61.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments held in Trust Account</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">246,312,667</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2018</div></div></div><div><table style="border: none;border-collapse: collapse;margin-bottom: .001pt;width: 100%;"><tr><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Description</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted&#160;Prices&#160;in Active&#160;</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Markets (Level 1)</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant&#160;Other</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Observable&#160;Inputs</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 2)</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td><td colspan="2" style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: center; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant&#160;Other&#160;</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable&#160;Inputs</div></div><br/><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 3)</div></div></div></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 1.0pt;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td></tr><tr><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 61.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: justify; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments held in Trust Account</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">244,890,301</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 10.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; text-align: right; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8212;</div></div></td><td style="background: #cceeff;border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0pt;padding-left: 0;padding-right: 0;padding-top: 0pt;vertical-align: bottom;width: 1.0%;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; line-height: normal; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 9&#8201;&#8212;&#8201;Stockholders&#8217; Equity</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Stock</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8201;&#8212;&#8201;The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of&#8201;$0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company&#8217;s board of directors. At March 31, 2019 and December 31, 2018, there were no shares of preferred stock issued or outstanding.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Common Stock</div></div></div><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">&#8201;&#8212;&#8201;The Company is authorized to issue 400,000,000 shares of common stock with a par value of&#8201;$0.0001 per share. Holders of shares of common stock are entitled to one vote for each share. At March 31, 2019 and December 31, 2018, there were 30,470,640 shares of common stock issued or outstanding, including an aggregate of 22,397,771 and 22,576,796 shares of common stock classified outside of subject to possible redemption, respectively.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> if, and only if, the reported last sale price of the Company&#8217;s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrantholders. upon not less than 30 days&#8217; prior written notice of redemption; and 0.01 30470640 30470640 <div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 10&#8201;&#8212;&#8201;Subsequent Events</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 0.25in; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: 'times new roman', 'serif';font-size: 10pt;margin-bottom: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><div style="font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were available to be issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 11.50 11.50 9.84 9.60 0.650 0.60 0.878 0.86 P5Y8M19D P5Y11M19D 0.0226 0.0255 0.00 0.00 0.150 0.150 100000 10-Q false 2019-03-31 2019 Q1 Graf Industrial Corp. 0001745317 --12-31 Non-accelerated Filer GRAF 30470640 true false true xbrli:shares iso4217:USD xbrli:pure iso4217:USD xbrli:shares The discount for lack of marketability relates only to the Private Placement Warrants. EX-101.SCH 7 graf-20190331.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - CONDENSED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - CONDENSED STATEMENT OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - CONDENSED STATEMENT OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - Description of Organization and Business Operations link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Initial Public Offering link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Private Placement link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Warrant Liability link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Warrant Liability (Tables) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Description of Organization and Business Operations (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Summary of Significant Accounting Policies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Initial Public Offering (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Private Placement (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Related Party Transactions (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Commitments and Contingencies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Warrant Liability (Details) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Warrant Liability (Details 1) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Warrant Liability (Details 2) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Warrant Liability (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Fair Value Measurements (Details Textual) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Stockholders' Equity (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 graf-20190331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 graf-20190331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 graf-20190331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 11 graf-20190331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.19.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2019
May 15, 2019
Document and Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2019  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q1  
Entity Registrant Name Graf Industrial Corp.  
Entity Central Index Key 0001745317  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Trading Symbol GRAF  
Entity Common Stock, Shares Outstanding   30,470,640
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Small Business true  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED BALANCE SHEETS - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash $ 1,174,616 $ 1,440,897
Prepaid expenses 129,752 101,363
Total current assets 1,304,368 1,542,260
Investments held in Trust Account 246,312,667 244,890,301
Total Assets 247,617,035 246,432,561
Current liabilities:    
Accounts payable 134,309 110,177
Accrued expenses 10,000 100,000
Franchise tax payable 50,000 103,013
Income tax payable 507,027 214,655
Warrant liability 17,937,987 15,136,749
Total current liabilities 18,639,323 15,664,594
Commitments and Contingencies
Common stock, $0.0001 par value; 22,397,771 and 22,576,796 shares subject to possible redemption (at $10.00 per share) at March 31, 2019 and December 31, 2018, respectively 223,977,710 225,767,960
Stockholders' Equity:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding 0 0
Common stock, $0.0001 par value; 400,000,000 shares authorized; 8,072,869 and 7,893,844 shares issued and outstanding (excluding 22,397,771 and 22,576,796 shares subject to possible redemption) at March 31, 2019 and December 31, 2018, respectively 807 789
Additional paid-in capital 2,698,080 923,412
Retained earnings 2,301,115 4,075,806
Total stockholders' equity 5,000,002 5,000,007
Total Liabilities and Stockholders' Equity $ 247,617,035 $ 246,432,561
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares
Mar. 31, 2019
Dec. 31, 2018
Temporary Equity, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Temporary Equity, Shares Outstanding 22,397,771 22,576,796
Temporary Equity, Redemption Price Per Share $ 10.00 $ 10.00
Preferred Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Preferred Stock, Shares Authorized 1,000,000 1,000,000
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
Common Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001
Common Stock, Shares Authorized 400,000,000 400,000,000
Common Stock, Shares, Issued 8,072,869 7,893,844
Common Stock, Shares, Outstanding 8,072,869 7,893,844
Common stock possible redemption 22,397,771 22,576,796
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED STATEMENT OF OPERATIONS
3 Months Ended
Mar. 31, 2019
USD ($)
$ / shares
shares
Operating expenses:  
General and administrative costs $ 103,447
Loss from operations (103,447)
Other incomes:  
Investment income on Trust Account 1,422,366
Change in fair value of warrant liability (2,801,238)
Total other incomes (1,378,872)
Income before income tax expense (1,482,319)
Income tax expense (292,372)
Net loss $ (1,774,691)
Weighted average shares outstanding of Public Shares | shares 24,376,512
Basic and diluted net income per share, Public Shares | $ / shares $ 0.05
Weighted average shares outstanding of Founder Shares | shares 6,094,128
Basic and diluted net loss per share, Founder Shares | $ / shares $ (0.48)
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - 3 months ended Mar. 31, 2019 - USD ($)
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings (Accumulated Deficit) [Member]
Balance at Dec. 31, 2018 $ 5,000,007 $ 789 $ 923,412 $ 4,075,806
Balance (in shares) at Dec. 31, 2018   7,893,844    
Additional offering costs (15,564) $ 0 (15,564) 0
Shares subject to possible redemption 1,790,250 $ 18 1,790,232 0
Shares subject to possible redemption (in shares)   179,025    
Net loss (1,774,691) $ 0 0 (1,774,691)
Balance at Mar. 31, 2019 $ 5,000,002 $ 807 $ 2,698,080 $ 2,301,115
Balance (in shares) at Mar. 31, 2019   8,072,869    
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED STATEMENT OF CASH FLOWS
3 Months Ended
Mar. 31, 2019
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (1,774,691)
Adjustments to reconcile net income to net cash used in operating activities:  
Income earned on investment held in Trust Account (1,422,366)
Change in fair value of warrant liability 2,801,238
Changes in operating assets and liabilities:  
Prepaid expenses (28,389)
Accounts payable 24,132
Accrued expenses (5,000)
Franchise tax payable (53,013)
Income tax payable 292,372
Net cash used in operating activities (165,717)
Cash Flows from Financing Activities:  
Payment of offering costs (100,564)
Net cash provided by financing activities (100,564)
Net change in cash (266,281)
Cash - beginning of the period 1,440,897
Cash - end of the period 1,174,616
Supplemental disclosure of noncash activities:  
Change in value of common stock subject to possible redemption $ (1,790,250)
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.19.1
Description of Organization and Business Operations
3 Months Ended
Mar. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Note 1 — Description of Organization and Business Operations
 
Graf Industrial Corp. (the “Company”) is a blank check company incorporated in Delaware on June 26, 2018. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).
 
The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.
 
As of March 31, 2019, the Company had not commenced any operations. All activity up to March 31, 2019 relates to the Company’s formation and preparation for the initial public offering (“Initial Public Offering”), and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.
 
The registration statement for the Company’s Initial Public Offering was declared effective on October 15, 2018. On October 18, 2018, the Company consummated the Initial Public Offering of 22,500,000 units (the “Units” and, with respect to the shares of common stock included in the Units offered, the “Public Shares”), generating gross proceeds of $225 million, and incurred underwriting commissions of $4.5 million. On October 25, 2018, the Company consummated the closing of the sale of 1,876,512 additional Units upon receiving notice of the underwriters’ election to partially exercise their overallotment option (the “Over-allotment”), generating additional gross proceeds of approximately $18.8 million, and incurred additional underwriting commissions of $375,302 (Note 3).
 
Simultaneously with the closing of the Initial Public Offering and the Over-allotment, the Company consummated the private placement (“Private Placement”) of 14,150,605 warrants (the “Private Placement Warrants”) at a price of $0.50 per Private Placement Warrant, with the Sponsor, generating gross proceeds of approximately $7.08 million (Note 4).
 
Upon the closing of the Initial Public Offering, the Over-allotment and the Private Placement, approximately $243.8 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A. maintained by Continental Stock Transfer & Trust Company, acting as trustee (“Trust Account”).
The proceeds held in the Trust Account was invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination, (ii) the redemption of any Public Shares properly submitted in connection with a stockholder vote to amend the Company’s Second Amended and Restated Certificate of Incorporation (the “Second Amended and Restated Certificate of Incorporation”) to modify the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 18 months from the closing of its Initial Public Offering or to provide for redemption in connection with a Business Combination and (iii) the redemption of the Company’s Public Shares if the Company is unable to complete a Business Combination within 18 months from the closing of its Initial Public Offering, subject to applicable law.
 
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, the Over-allotment and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. New York Stock Exchange (“NYSE”) rules require that the initial Business Combination must occur with one or more operating businesses or assets with a
fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions)
. The Company will only complete a Business Combination if the post-transaction company owns or
acquires 50% or more of the outstanding voting securities of the target
or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
 
The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption were recorded at a redemption value and classified as temporary equity in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to the Second Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Company’s Sponsor, officers and directors have agreed to vote their Founder Shares (as defined below in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction.
 
The Sponsor and the Company’s officers and directors have agreed (a) to waive their redemption rights with respect to their Founder Shares and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose an amendment to the Second Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination or to provide for redemption in connection with a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
 
If the Company is unable to complete a Business Combination within 18 months from the closing of the Initial Public Offering (by April 18, 2020) (the “Combination Period”), the Company will
(i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law,
and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.
 
The Sponsor and the Company’s officers and directors have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the officers, directors, the Sponsor or any of its members or their affiliates acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. Pursuant to the terms of the business combination marketing agreement (see Note 6), no fee will be payable if the Company does not complete a Business Combination. In the event that the Company does not complete a Business Combination and subsequently liquidates, the amount of such fee will be included with the funds held in the trust account that will be available to fund the redemption of Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).
 
In order to protect the amounts held in the Trust Account, the Sponsor has agreed to indemnify the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of  (i) $10.00 per Public Share or (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
 
Going Concern
 
As of March 31, 2019, the Company had approximately $1.2 million outside of the Trust Account, approximately $2.6 million of investment income available in the Trust Account to pay for franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), and a working capital surplus of approximately $603,000.
 
Through March 31, 2019, the Company’s liquidity needs have been satisfied through receipt of a $25,000 capital contribution from the Sponsor in exchange for the issuance of the Founder Shares (Note 5) to the Sponsor, $130,100 in loans and advances from the Sponsor and officer, and the net proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the loans and the advances to the Sponsor and officer in full on October 18, 2018.
 
In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide Working Capital Loans (as defined in Note 5) to the Company. As of March 31, 2019, there were no Working Capital Loans.
 
In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after April 18, 2020.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Significant Accounting Policies [Text Block]
Note 2 — Summary of Significant Accounting Policies
 
Basis of Presentation
 
The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2019 are not necessarily indicative of the results that may be expected through December 31, 2019.
 
The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company's Annual Report on Form 10-K filed by the Company with the SEC on April 1, 2019.
 
Emerging Growth Company
 
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
 
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
 
Use of Estimates
 
The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and the reported amounts of expenses during the period.
 
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
 
Offering Costs
 
Offering costs consist of legal and accounting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs were charged to stockholders’ equity upon the completion of the Initial Public Offering in October 2018.
 
Common Stock Subject to Possible Redemption
 
As discussed in Note 1, all of the 24,376,512 Public Shares may be redeemed under certain circumstances. In accordance with FASB ASC 480, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of FASB ASC 480. Although the Company did not specify a maximum redemption threshold, the Second Amended and Restated Certificate of Incorporation provides that in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets (stockholders’ equity) to be less than $5,000,001.
 
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the security at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock shall be affected by charges against additional paid-in capital. Accordingly, at March 31, 2019 and December 31, 2018, 22,397,771 and 22,576,796 Public Shares were classified outside of permanent equity, respectively.
 
Net Income Per Common Share
 
Net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the periods. The Company had not considered the effect of the warrants sold in the Initial Public Offering (including the consummation of the Over-allotment) and Private Placement to purchase an aggregate of 19,263,559 shares of the Company’s common stock in the calculation of diluted income per share, because their inclusion would be anti-dilutive under the treasury stock method.
 
The Company’s statement of operations includes a presentation of income per share for common stock subject to redemption in a manner similar to the two-class method of income per share. Net income per share, basic and diluted for Public Share is calculated by dividing the interest income earned on the Trust Account of approximately $1.4 million, net of applicable taxes and funds available to be withdrawn from the Trust Account, resulting in a total of approximately $1.2 million, by the weighted average number of Public Shares outstanding for the period. Net income per share, basic and diluted for Founder Shares (as defined in Note 5) is calculated by dividing the net income, less income attributable to Public Shares, by the weighted average number of Founder Shares outstanding for the period.
 
Income Taxes
 
The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. 
As of March 31, 2019 and December 31, 2018, the Company has a deferred tax asset of approximately $70,000 and $38,000, respectively, which has a full valuation allowance recorded against it.
 
The Company’s currently taxable income primarily consists of interest income on the Trust Account. The Company’s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three months ended March 31, 2019, the Company recorded income tax expense of approximately $292,000, primarily related to interest income earned on the Trust Account. The Company’s effective tax rate for the three months ended March 31, 2019 was approximately 20.9% which differs from the expected income tax rate due to the start-up costs (discussed above) which are not currently deductible.
 
FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2019 and December 31, 2018. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
 
Concentration of Credit Risk
 
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At March 31, 2019 and December 31, 2018, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
 
Fair Value of Financial Instruments
 
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
 
Fair Value Measurements
 
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
 
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
 
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
 
Warrant Liability
 
The Company accounts for certain common stock warrants outstanding as a liability at fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until the earlier of the consummation of the Business Combination or 15 months from the closing of the Initial Public Offering, and any change in fair value is recognized in the Company’s statements of operations. The fair value of the warrant liability is estimated using a binomial Monte-Carlo options pricing model, at each measurement date.
 
Recent Accounting Pronouncements
 
Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.
 
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.19.1
Initial Public Offering
3 Months Ended
Mar. 31, 2019
Stockholders' Equity Note [Abstract]  
Initial Public Offering [Text Block]
Note 3 — Initial Public Offering
 
The Company sold an aggregate of 24,376,512 Units, including 1,876,512 Units upon the underwriters’ election to partially exercise their overallotment option, at a price of $10.00 per Unit in the Initial Public Offering. Each Unit consists of one share of common stock and one redeemable warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one-half of one share of common stock at a price of  $11.50 per whole share, provided that if the Company has not consummated a Business Combination within 15 months from the closing of the Initial Public Offering, each Public Warrant will entitle the holder thereof to purchase three-quarters of one share of common stock at a price of  $11.50 per whole share, subject to adjustment in either case (see Note 7). The Private Placement Warrants and the Public Warrants were classified as a liability at issuance due to this potential adjustment to the settlement amount.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.19.1
Private Placement
3 Months Ended
Mar. 31, 2019
Stockholders' Equity Note [Abstract]  
Private Placement [Text Block]
Note 4 — Private Placement
 
Concurrently with the closing of the Initial Public Offering and the Over-allotment, the Sponsor purchased an aggregate of 14,150,605 Private Placement Warrants at a price of  $0.50 per Private Placement Warrant, for an aggregate purchase price of approximately $7.08 million. Each Private Placement Warrant has the same terms as the Public Warrants. A portion of the net proceeds from the sale of the Private Placement Warrants were added to the proceeds from the Initial Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants and all underlying securities will expire worthless. The Sponsor has agreed not to transfer, assign or sell any of the Private Placement Warrants until the date that is 30 days after the completion of a Business Combination.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Related Party Transactions
3 Months Ended
Mar. 31, 2019
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]
Note 5 — Related Party Transactions
 
Founder Shares
 
On June 26, 2018, the Sponsor purchased 8,625,000 shares (the “Founder Shares”) of the Company’s common stock for an aggregate price of $25,000. On September 13, 2018, the Sponsor returned to the Company, at no cost, 2,156,250 shares of common stock, which the Company cancelled, resulting in the Sponsor holding 6,468,750 Founder Shares. On October 9, 2018, the Sponsor transferred 25,000 Founder Shares at the same per-share price paid by the Sponsor to each of Keith Abell and Sabrina McKee, two of the Company’s directors (then director-nominees), resulting in the Sponsor holding 6,418,750 Founder Shares.
 
The Founder Shares included an aggregate of up to 843,750 shares subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On October 25, 2018, the underwriters partially exercised their over-allotment option; thus, an aggregate of 374,622 Founder Shares was forfeited.
 
The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.
 
Related Party Loans
 
During the period from June 26, 2018 (inception) through December 31, 2018, the Sponsor had loaned the Company an aggregate of  $130,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Promissory Note”) and James A. Graf had advanced the Company $100 in connection with the initial establishment of a bank account. The Promissory Note and the advance from James A. Graf were non-interest bearing. The Company repaid the Promissory Note and the advances to James A. Graf on October 18, 2018.
 
In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into additional warrants at a price of  $0.50 (or $0.75 if the Company has not consummated a Business Combination within 15 months from the closing of the Initial Public Offering) per warrant. As of March 31, 2019, there were no Working Capital Loans.
 
Administrative Support Agreement
 
The Company agreed commencing on the effective date of the Initial Public Offering through the earlier of the Company’s consummation of a Business Combination and its liquidation, to reimburse an affiliate of its Sponsor up to $5,000 per month for office space, utilities and secretarial and administrative support on an at-cost basis to the extent such office space, utilities and support is not contracted with the Company directly.
 
The Company recorded and paid approximately $2,600 in expenses in connection with such agreement on the accompanying Statement of Operations for the three months ended March 31, 2019.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block]
Note 6 — Commitments and Contingencies
 
Registration Rights
 
The holders of the Founder Shares, Private Placement Warrants (and any shares of common stock issuable upon the exercise of the Private Placement Warrants), and securities that may be issued upon conversion of Working Capital Loans will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of Initial Public Offering, requiring the Company to register such securities for resale. The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
 
Underwriting Agreement
 
The Company granted the underwriters a 45-day option from the date of the prospectus relating to the Initial Public Offering to purchase up to 3,375,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters partially exercised this option on October 25, 2018 to purchase 1,876,512 additional Units.
 
The underwriters were entitled to a cash underwriting discount of $0.20 per Unit, or approximately $4.88 million in the aggregate, which was paid upon the closing of the Initial Public Offering.
 
Business Combination Marketing Agreement
 
The Company has engaged EarlyBirdCapital and Oppenheimer & Co. Inc. as advisors in connection with the Business Combination. The Company will pay EarlyBirdCapital and Oppenheimer & Co. Inc. for such services upon the consummation of the Business Combination (i) a cash fee in an amount equal to 3.5% of the gross proceeds of the Initial Public Offering (exclusive of any applicable finders’ fees which might become payable) an amount equal to up to 40% of which may, in the Company’s discretion, be allocated by the Company to other FINRA members, plus (ii) 150,000 shares of common stock to be issued to EarlyBirdCapital and/or its designees. EarlyBirdCapital and/or its designees will be entitled to registration rights requiring the Company to register such shares for resale. The Company has agreed to use its best efforts to effect such registration in connection with the consummation of the Business Combination or, if not then reasonably practicable, to use the Company’s best efforts to file a registration statement covering such shares within 15 days of the closing of the Business Combination. Pursuant to the terms of the business combination marketing agreement, no fee will be due if the Company does not complete a Business Combination. As of March 31, 2019, none of the above services have been substantially performed and accordingly no amounts have been recorded in the accompanying unaudited condensed financial statements.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.19.1
Warrant Liability
3 Months Ended
Mar. 31, 2019
Warrant Liability [Abstract]  
Warrant liabilty [Text Block]
Note 7 — Warrant Liability
 
The Company has outstanding warrants to purchase an aggregate of 19,263,559 shares of the Company’s common stock issued in connection with the Initial Public Offering and the Private Placement (including warrants issued in connection with the consummation of the Over-allotment).
 
The Public Warrants may only be exercised for a whole number of shares. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of common stock issuable upon exercise of the Public Warrants. The Company will use its best efforts to cause the same to become effective and to maintain a current prospectus relating to those shares of common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective by the 60thbusiness day after the closing of a Business Combination, warrantholders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.
 
Once the warrants become exercisable, the Company may redeem the Public Warrants:
 
 
in whole and not in part;
 
at a price of $
0.01
per warrant;
 
upon not less than 30 days’ prior written notice of redemption; and
 
if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrantholders.
 
If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants.
 
The Private Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the Initial Public Offering, except that the Private Placement Warrants and the common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. The Private Placement Warrants will be redeemable by the Company on the same basis as the Public Warrants.
 
If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
 
The Company utilizes a binomial Monte-Carlo options pricing model to value the warrants at each reporting period, with changes in fair value recognized in the Statement of Operations. As such, the Company recorded $18,584,922 of warrant liabilities upon issuance as of October 18, 2018. For the three months ended March 31, 2019, the Company recorded a change in the fair value of the warrant liabilities in the amount of approximately $2.8 million on the statement of operations, resulting in warrant liabilities of $17,937,987 as of March 31, 2019 on the balance sheet.
 
The change in fair value of the warrant liabilities is summarized as follows:
 
Warrant liabilities at December 31, 2018
 
$
15,136,749
 
Change in fair value of warrant liabilities
 
 
2,801,238
 
Warrant liabilities at March 31, 2019
 
$
17,937,987
 
 
The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates to remain at zero.
 
There were no transfers between Levels 1, 2 or 3 during the three months ended March 31, 2019.
 
The following table provides quantitative information regarding Level 3 fair value measurements as of March 31, 2019 and December 31, 2018:
 
 
 
March 31,

2019
 
 
December 31, 

2018
 
Exercise price
 
$
11.50
 
 
$
11.50
 
Share price
 
$
9.84
 
 
$
9.60
 
Volatility
 
 
65.0
%
 
 
60
%
Probability of completing a Business Combination
 
 
87.8
%
 
 
86
%
Expected life of the options to convert
 
 
5.72
 
 
 
5.97
 
Risk-free rate
 
 
2.26
%
 
 
2.55
%
Dividend yield
 
 
0.0
%
 
 
0.0
%
Discount for lack of marketability (1)
 
 
15.0
%
 
 
15.0
%
 
 
(1)
The discount for lack of marketability relates only to the Private Placement Warrants.
 
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2019 and December 31, 2018, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
Description
 
Level
 
 
March 31,

2019
 
Liabilities:
 
 
 
 
 
 
 
 
Warrant liabilities
 
 
3
 
 
$
17,937,987
 
 
 
 
 
 
 
 
 
 
 
Description
 
Level
 
 
December 31, 

2018
 
Liabilities:
 
 
 
 
 
 
 
 
Warrant liabilities
 
 
3
 
 
$
15,136,749
 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]  
Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]
Note 8 — Fair Value Measurements
 
The following table presents information about the Company’s assets that are measured on a recurring basis as of March 31, 2019 and December 31, 2018 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.
 
March 31, 2019
 
Description
 
Quoted Prices in Active 

Markets (Level 1)
 
 
Significant Other

Observable Inputs

(Level 2)
 
 
Significant Other 

Unobservable Inputs

(Level 3)
 
Investments held in Trust Account
 
$
246,312,667
 
 
 
 
 
 
 
 
December 31, 2018
Description
 
Quoted Prices in Active 

Markets (Level 1)
 
 
Significant Other
Observable Inputs

(Level 2)
 
 
Significant Other 

Unobservable Inputs

(Level 3)
 
Investments held in Trust Account
 
$
244,890,301
 
 
 
 
 
 
 
 
At March 31, 2019 and December 31, 2018, approximately $2,400 and $500 of the balance in the Trust Account was held in cash, respectively.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity
3 Months Ended
Mar. 31, 2019
Equity [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
Note 9 — Stockholders’ Equity
 
Preferred Stock
 — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At March 31, 2019 and December 31, 2018, there were no shares of preferred stock issued or outstanding.
 
Common Stock
 — The Company is authorized to issue 400,000,000 shares of common stock with a par value of $0.0001 per share. Holders of shares of common stock are entitled to one vote for each share. At March 31, 2019 and December 31, 2018, there were 30,470,640 shares of common stock issued or outstanding, including an aggregate of 22,397,771 and 22,576,796 shares of common stock classified outside of subject to possible redemption, respectively.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.19.1
Subsequent Events
3 Months Ended
Mar. 31, 2019
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
Note 10 — Subsequent Events
 
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited condensed financial statements were available to be issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2019
Accounting Policies [Abstract]  
Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation
 
The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2019 are not necessarily indicative of the results that may be expected through December 31, 2019.
 
The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company's Annual Report on Form 10-K filed by the Company with the SEC on April 1, 2019.
Start-up Activities, Cost Policy [Policy Text Block]
Emerging Growth Company
 
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
 
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
 
The preparation of the unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and the reported amounts of expenses during the period.
 
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Offering Costs [Policy Text Block]
Offering Costs
 
Offering costs consist of legal and accounting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs were charged to stockholders’ equity upon the completion of the Initial Public Offering in October 2018.
Common stock subject to possible redemption [Policy Text Block]
Common Stock Subject to Possible Redemption
 
As discussed in Note 1, all of the 24,376,512 Public Shares may be redeemed under certain circumstances. In accordance with FASB ASC 480, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of FASB ASC 480. Although the Company did not specify a maximum redemption threshold, the Second Amended and Restated Certificate of Incorporation provides that in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets (stockholders’ equity) to be less than $5,000,001.
 
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the security at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock shall be affected by charges against additional paid-in capital. Accordingly, at March 31, 2019 and December 31, 2018, 22,397,771 and 22,576,796 Public Shares were classified outside of permanent equity, respectively.
Earnings Per Share, Policy [Policy Text Block]
Net Income Per Common Share
 
Net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the periods. The Company had not considered the effect of the warrants sold in the Initial Public Offering (including the consummation of the Over-allotment) and Private Placement to purchase an aggregate of 19,263,559 shares of the Company’s common stock in the calculation of diluted income per share, because their inclusion would be anti-dilutive under the treasury stock method.
 
The Company’s statement of operations includes a presentation of income per share for common stock subject to redemption in a manner similar to the two-class method of income per share. Net income per share, basic and diluted for Public Share is calculated by dividing the interest income earned on the Trust Account of approximately $1.4 million, net of applicable taxes and funds available to be withdrawn from the Trust Account, resulting in a total of approximately $1.2 million, by the weighted average number of Public Shares outstanding for the period. Net income per share, basic and diluted for Founder Shares (as defined in Note 5) is calculated by dividing the net income, less income attributable to Public Shares, by the weighted average number of Founder Shares outstanding for the period.
Income Tax, Policy [Policy Text Block]
Income Taxes
 
The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. 
As of March 31, 2019 and December 31, 2018, the Company has a deferred tax asset of approximately $70,000 and $38,000, respectively, which has a full valuation allowance recorded against it.
 
The Company’s currently taxable income primarily consists of interest income on the Trust Account. The Company’s general and administrative costs are generally considered start-up costs and are not currently deductible. During the three months ended March 31, 2019, the Company recorded income tax expense of approximately $292,000, primarily related to interest income earned on the Trust Account. The Company’s effective tax rate for the three months ended March 31, 2019 was approximately 20.9% which differs from the expected income tax rate due to the start-up costs (discussed above) which are not currently deductible.
 
FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2019 and December 31, 2018. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Concentration of Credit Risk
 
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At March 31, 2019 and December 31, 2018, the Company had not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair Value of Financial Instruments
 
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
Fair Value Measurement, Policy [Policy Text Block]
Fair Value Measurements
 
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
 
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
 
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Warrant Liability [Policy Text Block]
Warrant Liability
 
The Company accounts for certain common stock warrants outstanding as a liability at fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until the earlier of the consummation of the Business Combination or 15 months from the closing of the Initial Public Offering, and any change in fair value is recognized in the Company’s statements of operations. The fair value of the warrant liability is estimated using a binomial Monte-Carlo options pricing model, at each measurement date.
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
 
Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.
 
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Warrant Liability (Tables)
3 Months Ended
Mar. 31, 2019
Warrant Liability [Abstract]  
Schedule of change in fairvalue warrant liabiltiy [Table Text Block]
The change in fair value of the warrant liabilities is summarized as follows:
 
Warrant liabilities at December 31, 2018
 
$
15,136,749
 
Change in fair value of warrant liabilities
 
 
2,801,238
 
Warrant liabilities at March 31, 2019
 
$
17,937,987
 
Disclousure of quantitative information of level 3 [Table Text Blcok]
The following table provides quantitative information regarding Level 3 fair value measurements as of March 31, 2019 and December 31, 2018:
 
 
 
March 31,

2019
 
 
December 31, 

2018
 
Exercise price
 
$
11.50
 
 
$
11.50
 
Share price
 
$
9.84
 
 
$
9.60
 
Volatility
 
 
65.0
%
 
 
60
%
Probability of completing a Business Combination
 
 
87.8
%
 
 
86
%
Expected life of the options to convert
 
 
5.72
 
 
 
5.97
 
Risk-free rate
 
 
2.26
%
 
 
2.55
%
Dividend yield
 
 
0.0
%
 
 
0.0
%
Discount for lack of marketability (1)
 
 
15.0
%
 
 
15.0
%
 
 
(1)
The discount for lack of marketability relates only to the Private Placement Warrants.
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2019 and December 31, 2018, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
Description
 
Level
 
 
March 31,

2019
 
Liabilities:
 
 
 
 
 
 
 
 
Warrant liabilities
 
 
3
 
 
$
17,937,987
 
 
 
 
 
 
 
 
 
 
 
Description
 
Level
 
 
December 31, 

2018
 
Liabilities:
 
 
 
 
 
 
 
 
Warrant liabilities
 
 
3
 
 
$
15,136,749
 
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]  
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]
The following table presents information about the Company’s assets that are measured on a recurring basis as of March 31, 2019 and December 31, 2018 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.
 
March 31, 2019
 
Description
 
Quoted Prices in Active 

Markets (Level 1)
 
 
Significant Other

Observable Inputs

(Level 2)
 
 
Significant Other 

Unobservable Inputs

(Level 3)
 
Investments held in Trust Account
 
$
246,312,667
 
 
 
 
 
 
 
 
December 31, 2018
Description
 
Quoted Prices in Active 

Markets (Level 1)
 
 
Significant Other
Observable Inputs

(Level 2)
 
 
Significant Other 

Unobservable Inputs

(Level 3)
 
Investments held in Trust Account
 
$
244,890,301
 
 
 
 
 
 
 
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Description of Organization and Business Operations (Details Textual) - USD ($)
1 Months Ended 3 Months Ended
Oct. 25, 2018
Oct. 18, 2018
Jun. 27, 2018
Mar. 31, 2019
Class of Warrant or Right, Exercise Price of Warrants or Rights       $ 11.50
Proceeds from Issuance Initial Public Offering       $ 4,880,000
Share Price       $ 12.00
Business Acquisition, Description of Acquired Entity       The proceeds held in the Trust Account was invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination, (ii) the redemption of any Public Shares properly submitted in connection with a stockholder vote to amend the Company’s Second Amended and Restated Certificate of Incorporation (the “Second Amended and Restated Certificate of Incorporation”) to modify the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 18 months from the closing of its Initial Public Offering or to provide for redemption in connection with a Business Combination and (iii) the redemption of the Company’s Public Shares if the Company is unable to complete a Business Combination within 18 months from the closing of its Initial Public Offering, subject to applicable law.​​​​​​​
Description Of Business Combination       fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions)
Business Combination Percentage of Voting Interests Description       acquires 50% or more of the outstanding voting securities of the target
Business Combination Tangible Assets Net       $ 5,000,001
Percentage Of Public Shares To Be Redeemed       100.00%
Proceeds from Issuance of Common Stock       $ 25,000
Cash and Cash Equivalents, at Carrying Value       1,200,000
Working capital surplus       $ 603,000
Effect Of Incompletion Of Business Combination       (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay franchise and income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law,
Interest Paid, Including Capitalized Interest, Operating and Investing Activities       $ 100,000
Gain (Loss) on Sale of Trust Assets to Pay Expenses       2,600,000
Sponsor [Member]        
Stock Issued During Period, Shares, New Issues     8,625,000  
Stock Issued During Period, Value, New Issues     $ 25,000  
Proceeds from Related Party Debt       $ 130,100
IPO [Member]        
Stock Issued During Period, Shares, New Issues   22,500,000   24,376,512
Stock Issued During Period, Value, New Issues   $ 225,000,000    
Share Price $ 10.00      
Underwriting Commissions Incurred   $ 4,500,000    
Over-Allotment Option [Member]        
Stock Issued During Period, Shares, New Issues 1,876,512     1,876,512
Stock Issued During Period, Value, New Issues $ 18,800,000      
Underwriting Commissions Incurred 375,302      
Private Placement [Member]        
Number Of Warrants Issued       14,150,605
Class of Warrant or Right, Exercise Price of Warrants or Rights       $ 0.50
Proceeds from Issuance of Warrants       $ 7,080,000
Proceeds from Issuance Initial Public Offering $ 243,800,000      
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies (Details Textual) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 19,263,559  
Cash, FDIC Insured Amount $ 250,000  
Business Combination Tangible Assets Net 5,000,001  
Investment Income, Interest $ 1,400,000  
Reclassifications of Shares Outside Of Permanent Equity 22,397,771 22,576,796
Funds Available For Withdrawn From Trust $ 1,200,000  
Deferred Tax Assets, Valuation Allowance 70,000 $ 38,000
Income Tax Expense (Benefit) 292,372  
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $ 0 $ 0
Effective Income Tax Rate Reconciliation, Percent 20.90%  
Common Stock [Member]    
Stock Issued During Period, Shares, New Issues 24,376,512  
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Initial Public Offering (Details Textual) - $ / shares
1 Months Ended 3 Months Ended
Oct. 25, 2018
Oct. 18, 2018
Mar. 31, 2019
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 11.50
IPO [Member]      
Stock Issued During Period, Shares, New Issues   22,500,000 24,376,512
Shares Issued, Price Per Share     $ 10.00
Over-Allotment Option [Member]      
Stock Issued During Period, Shares, New Issues 1,876,512   1,876,512
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Private Placement (Details Textual)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2019
USD ($)
$ / shares
shares
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 11.50
Private Placement [Member]  
Number Of Warrants Issued | shares 14,150,605
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 0.50
Proceeds from Issuance of Warrants | $ $ 7,080
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.19.1
Related Party Transactions (Details Textual) - USD ($)
1 Months Ended 3 Months Ended
Oct. 09, 2018
Sep. 13, 2018
Oct. 25, 2018
Jun. 27, 2018
Mar. 31, 2019
Dec. 31, 2018
Common Stock, Shares, Outstanding   6,468,750     8,072,869 7,893,844
Number Of Shares Held By Sponsor 6,418,750          
Number Of Shares Subject To Forfeiture         843,750  
Stock Repurchased During Period, Shares     374,622      
Share Price         $ 12.00  
Notes Payable, Related Parties, Current           $ 100
Debt Conversion, Original Debt, Amount         $ 1,500,000  
Debt Instrument, Convertible, Conversion Price         $ 0.50  
Debt Instrument Convertible Conversion Price Description         $0.75 if the Company has not consummated a Business Combination within 15 months from the closing of the Initial Public Offering) per warrant.  
Management Fee Expense         $ 5,000  
Related Party Transaction, Expenses from Transactions with Related Party         $ 2,600  
Director [Member]            
Number Of Shares Transferred 25,000          
Sponsor [Member]            
Stock Issued During Period, Shares, New Issues       8,625,000    
Stock Issued During Period, Value, New Issues       $ 25,000    
Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation   2,156,250        
Equity Method Investment, Ownership Percentage         20.00%  
Notes Payable, Related Parties, Current           $ 130,000
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended
Oct. 25, 2018
Mar. 31, 2019
Purchase of Initial Public Offering   3,375,000
Purchase of Initial Public Offering Exercised 1,876,512  
Cash Underwriting Discount Per Share   $ 0.20
Business Combination Cash Fee Percentage   3.50%
Business Combination Finders Fees Payable Percentage   40.00%
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares   150,000
Proceeds from Issuance Initial Public Offering   $ 4,880
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.19.1
Warrant Liability (Details)
3 Months Ended
Mar. 31, 2019
USD ($)
Warrant liabilities $ 15,136,749
Change in fair value of warrant liabilities 2,801,238
Warrant liabilities $ 17,937,987
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.19.1
Warrant Liability (Details 1) - $ / shares
3 Months Ended 6 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Share price $ 12.00  
Fair Value, Inputs, Level 3 [Member] | Warrant [Member]    
Exercise price 11.50 $ 11.50
Share price $ 9.84 $ 9.60
Volatility 65.00% 60.00%
Probability of completing a Business Combination 87.80% 86.00%
Expected life of the options to convert 5 years 8 months 19 days 5 years 11 months 19 days
Risk-free rate 2.26% 2.55%
Dividend yield 0.00% 0.00%
Discount for lack of marketability [1] 15.00% 15.00%
[1] The discount for lack of marketability relates only to the Private Placement Warrants.
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Warrant Liability (Details 2) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Liabilities [Abstract]    
Warrant liabilities $ 2,801,238  
Fair Value, Inputs, Level 3 [Member]    
Liabilities [Abstract]    
Warrant liabilities $ 17,937,987 $ 15,136,749
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Warrant Liability (Details Textual) - USD ($)
1 Months Ended 3 Months Ended
Oct. 18, 2018
Mar. 31, 2019
Dec. 31, 2018
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right   19,263,559  
Fair Value Adjustment of Warrants   $ 2,801,238  
Warrant liability   $ 17,937,987 $ 15,136,749
Temporary Equity, Redemption Price Per Share   $ 10.00 $ 10.00
Description of Covenants of Notice to Shareholders on Redemption   if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrantholders.  
Maximum [Member]      
Description Of Redemption Period   upon not less than 30 days’ prior written notice of redemption; and  
Warrant [Member]      
Stock Issued During Period, Value, New Issues $ 18,584,922    
Temporary Equity, Redemption Price Per Share   $ 0.01  
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements (Details) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Investments held in Trust Account $ 246,312,667 $ 244,890,301
Fair Value, Inputs, Level 1 [Member]    
Investments held in Trust Account 246,312,667 244,890,301
Fair Value, Inputs, Level 2 [Member]    
Investments held in Trust Account 0 0
Fair Value, Inputs, Level 3 [Member]    
Investments held in Trust Account $ 0 $ 0
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value Measurements (Details Textual) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Cash Equivalents, at Carrying Value $ 2,400 $ 500
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity (Details Textual) - $ / shares
Mar. 31, 2019
Dec. 31, 2018
Sep. 13, 2018
Preferred Stock, Shares Authorized 1,000,000 1,000,000  
Preferred Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001  
Common Stock, Shares Authorized 400,000,000 400,000,000  
Common Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001  
Common Stock, Shares, Outstanding 8,072,869 7,893,844 6,468,750
Preferred Stock, Shares Outstanding 0 0  
Common stock possible redemption 22,397,771 22,576,796  
Preferred Stock, Shares Issued 0 0  
Common Stock [Member]      
Common Stock, Shares, Outstanding 30,470,640 30,470,640  
EXCEL 44 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

_WNT2U2' M_SRFK?JX!*(]+/;.UN\;;=G$ /.?6V)2\\A%??(:$+#]Z=?93KF;4*;2ZCG, MKY3'E4<*'X<9A-Y5H#"XD'!;01,'BT&("-9?"2W(.:F@6/:([ 0U=CSVI,YS MB\Z>278A=(';]-&T'!^Y-"#%*<[K23GE_84% MHD]X3+96!^:19W_Q]&O8H?O"2F/<0C//#O;W?VOUUW /RV"4;%*;UMH:>%1F MX)3L=3PXM]Y>IW\J]HR?&]3F&M(6V.5#"J@Z[N0Q)N=!5%RF*2:U/6M77Z+^ MCRD*.+5_] [D@0&Y6,#?Z-.SXBFP&MS4YT55W+-< /:>W35U,2'W4V/\-L7: M+OR M&8_H+(DRUO!O6)X!SS+J'>GG_8*E9U$1E.P?1:Y>B?_%"

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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 46 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 47 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.1 html 50 156 1 true 14 0 false 4 false false R1.htm 1001 - Document - Document and Entity Information Sheet http://www.grafindustrialcorp.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1002 - Statement - CONDENSED BALANCE SHEETS Sheet http://www.grafindustrialcorp.com/role/CondensedBalanceSheets CONDENSED BALANCE SHEETS Statements 2 false false R3.htm 1003 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://www.grafindustrialcorp.com/role/CondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - CONDENSED STATEMENT OF OPERATIONS Sheet http://www.grafindustrialcorp.com/role/CondensedStatementOfOperations CONDENSED STATEMENT OF OPERATIONS Statements 4 false false R5.htm 1005 - Statement - CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.grafindustrialcorp.com/role/CondensedStatementOfChangesInStockholdersEquity CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 1006 - Statement - CONDENSED STATEMENT OF CASH FLOWS Sheet http://www.grafindustrialcorp.com/role/CondensedStatementOfCashFlows CONDENSED STATEMENT OF CASH FLOWS Statements 6 false false R7.htm 1007 - Disclosure - Description of Organization and Business Operations Sheet http://www.grafindustrialcorp.com/role/DescriptionOfOrganizationAndBusinessOperations Description of Organization and Business Operations Notes 7 false false R8.htm 1008 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.grafindustrialcorp.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 1009 - Disclosure - Initial Public Offering Sheet http://www.grafindustrialcorp.com/role/InitialPublicOffering Initial Public Offering Notes 9 false false R10.htm 1010 - Disclosure - Private Placement Sheet http://www.grafindustrialcorp.com/role/PrivatePlacement Private Placement Notes 10 false false R11.htm 1011 - Disclosure - Related Party Transactions Sheet http://www.grafindustrialcorp.com/role/RelatedPartyTransactions Related Party Transactions Notes 11 false false R12.htm 1012 - Disclosure - Commitments and Contingencies Sheet http://www.grafindustrialcorp.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 12 false false R13.htm 1013 - Disclosure - Warrant Liability Sheet http://www.grafindustrialcorp.com/role/WarrantLiability Warrant Liability Notes 13 false false R14.htm 1014 - Disclosure - Fair Value Measurements Sheet http://www.grafindustrialcorp.com/role/FairValueMeasurements Fair Value Measurements Notes 14 false false R15.htm 1015 - Disclosure - Stockholders' Equity Sheet http://www.grafindustrialcorp.com/role/StockholdersEquity Stockholders' Equity Notes 15 false false R16.htm 1016 - Disclosure - Subsequent Events Sheet http://www.grafindustrialcorp.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 1017 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.grafindustrialcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.grafindustrialcorp.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 1018 - Disclosure - Warrant Liability (Tables) Sheet http://www.grafindustrialcorp.com/role/WarrantLiabilityTables Warrant Liability (Tables) Tables http://www.grafindustrialcorp.com/role/WarrantLiability 18 false false R19.htm 1019 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.grafindustrialcorp.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.grafindustrialcorp.com/role/FairValueMeasurements 19 false false R20.htm 1020 - Disclosure - Description of Organization and Business Operations (Details Textual) Sheet http://www.grafindustrialcorp.com/role/DescriptionOfOrganizationAndBusinessOperationsDetailsTextual Description of Organization and Business Operations (Details Textual) Details http://www.grafindustrialcorp.com/role/DescriptionOfOrganizationAndBusinessOperations 20 false false R21.htm 1021 - Disclosure - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.grafindustrialcorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual Summary of Significant Accounting Policies (Details Textual) Details http://www.grafindustrialcorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies 21 false false R22.htm 1022 - Disclosure - Initial Public Offering (Details Textual) Sheet http://www.grafindustrialcorp.com/role/InitialPublicOfferingDetailsTextual Initial Public Offering (Details Textual) Details http://www.grafindustrialcorp.com/role/InitialPublicOffering 22 false false R23.htm 1023 - Disclosure - Private Placement (Details Textual) Sheet http://www.grafindustrialcorp.com/role/PrivatePlacementDetailsTextual Private Placement (Details Textual) Details http://www.grafindustrialcorp.com/role/PrivatePlacement 23 false false R24.htm 1024 - Disclosure - Related Party Transactions (Details Textual) Sheet http://www.grafindustrialcorp.com/role/RelatedPartyTransactionsDetailsTextual Related Party Transactions (Details Textual) Details http://www.grafindustrialcorp.com/role/RelatedPartyTransactions 24 false false R25.htm 1025 - Disclosure - Commitments and Contingencies (Details Textual) Sheet http://www.grafindustrialcorp.com/role/CommitmentsAndContingenciesDetailsTextual Commitments and Contingencies (Details Textual) Details http://www.grafindustrialcorp.com/role/CommitmentsAndContingencies 25 false false R26.htm 1026 - Disclosure - Warrant Liability (Details) Sheet http://www.grafindustrialcorp.com/role/WarrantLiabilityDetails Warrant Liability (Details) Details http://www.grafindustrialcorp.com/role/WarrantLiabilityTables 26 false false R27.htm 1027 - Disclosure - Warrant Liability (Details 1) Sheet http://www.grafindustrialcorp.com/role/WarrantLiabilityDetails1 Warrant Liability (Details 1) Details http://www.grafindustrialcorp.com/role/WarrantLiabilityTables 27 false false R28.htm 1028 - Disclosure - Warrant Liability (Details 2) Sheet http://www.grafindustrialcorp.com/role/WarrantLiabilityDetails2 Warrant Liability (Details 2) Details http://www.grafindustrialcorp.com/role/WarrantLiabilityTables 28 false false R29.htm 1029 - Disclosure - Warrant Liability (Details Textual) Sheet http://www.grafindustrialcorp.com/role/WarrantLiabilityDetailsTextual Warrant Liability (Details Textual) Details http://www.grafindustrialcorp.com/role/WarrantLiabilityTables 29 false false R30.htm 1030 - Disclosure - Fair Value Measurements (Details) Sheet http://www.grafindustrialcorp.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.grafindustrialcorp.com/role/FairValueMeasurementsTables 30 false false R31.htm 1031 - Disclosure - Fair Value Measurements (Details Textual) Sheet http://www.grafindustrialcorp.com/role/FairValueMeasurementsDetailsTextual Fair Value Measurements (Details Textual) Details http://www.grafindustrialcorp.com/role/FairValueMeasurementsTables 31 false false R32.htm 1032 - Disclosure - Stockholders' Equity (Details Textual) Sheet http://www.grafindustrialcorp.com/role/StockholdersEquityDetailsTextual Stockholders' Equity (Details Textual) Details http://www.grafindustrialcorp.com/role/StockholdersEquity 32 false false All Reports Book All Reports graf-20190331.xml graf-20190331.xsd graf-20190331_cal.xml graf-20190331_def.xml graf-20190331_lab.xml graf-20190331_pre.xml http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2018-01-31 true true ZIP 49 0001144204-19-026186-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-19-026186-xbrl.zip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end